-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LRM3wML/Xwjqx/oyZ1wwdS3E2+CWHYJJiP1d6f++1KLB2GYh1lL181S77RCReeu8 xB32HpaTHg1YSgfoxa72Ng== 0000893750-06-000207.txt : 20060710 0000893750-06-000207.hdr.sgml : 20060710 20060710152351 ACCESSION NUMBER: 0000893750-06-000207 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20060710 DATE AS OF CHANGE: 20060710 GROUP MEMBERS: BLACKSTONE CAPITAL PARTNERS V L.P. GROUP MEMBERS: BLACKSTONE FAMILY INVESTMENT PARTNERSHIP V L.P. GROUP MEMBERS: BLACKSTONE FAMILY INVESTMENT PARTNERSHIP V-A L.P. GROUP MEMBERS: BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C. GROUP MEMBERS: BLACKSTONE PARTICIPATION PARTNERSHIP V L.P. GROUP MEMBERS: BMA V L.L.C. GROUP MEMBERS: GRAND SLAM ACQUISITION CORP. GROUP MEMBERS: GRAND SLAM HOLDINGS, LLC GROUP MEMBERS: PETER G. PETERSON GROUP MEMBERS: STEPHEN A. SCHWARZMAN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENCORE MEDICAL CORP CENTRAL INDEX KEY: 0000944763 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 650572565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-50431 FILM NUMBER: 06953854 BUSINESS ADDRESS: STREET 1: 9800 METRIC BOULEVARD CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 5128329500 MAIL ADDRESS: STREET 1: 9800 METRIC BOULEVARD CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 19950531 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Grand Slam Acquisition Corp. CENTRAL INDEX KEY: 0001368577 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: C/O THE BLACKSTONE GROUP STREET 2: 345 PARK AVE. CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 212-583-5000 MAIL ADDRESS: STREET 1: C/O THE BLACKSTONE GROUP STREET 2: 345 PARK AVE. CITY: NEW YORK STATE: NY ZIP: 10154 SC 13D 1 sch13_d.txt SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ENCORE MEDICAL CORPORATION - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock ($0.001 par value) - -------------------------------------------------------------------------------- (Title of Class of Securities) 29256E109 - -------------------------------------------------------------------------------- (CUSIP Number) Chinh E. Chu The Blackstone Group 345 Park Avenue New York, New York 10154 (212) 583-5000 Copy to: William R. Dougherty, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, New York 10017 (212) 455-2000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 30, 2006 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If a filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Sections 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Exchange Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Grand Slam Acquisition Corp. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER ---------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY OWNED BY 10,879,760* EACH ---------------------------------------------------- REPORTING 9 SOLE DISPOSITIVE POWER PERSON ---------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 10,879,760 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON CO - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 2 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Grand Slam Holdings, LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER ------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY OWNED BY 10,879,760* EACH ------------------------------------------------------- REPORTING 9 SOLE DISPOSITIVE POWER PERSON WITH ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON OO - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 3 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 4 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Blackstone Capital Partners V L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF ------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY OWNED BY EACH 10,879,760* REPORTING ------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of this 5 Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 6 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Blackstone Family Investment Partnership V L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES ------------------------------------------------------ BENEFICIALLY OWNED BY 8 SHARED VOTING POWER EACH REPORTING 10,879,760* PERSON ----------------------------------------------------- WITH 9 SOLE DISPOSITIVE POWER ------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 7 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 8 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Blackstone Family Investment Partnership V-A L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES ------------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER EACH REPORTING 10,879,760* PERSON ------------------------------------------------------- WITH 9 SOLE DISPOSITIVE POWER -------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 9 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 10 CUSIP No. 29256E109 - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Blackstone Participation Partnership V L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES ------------------------------------------------------ BENEFICIALLY OWNED BY 8 SHARED VOTING POWER EACH REPORTING 10,879,760* PERSON ------------------------------------------------------ WITH 9 SOLE DISPOSITIVE POWER ------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 10,879,760* - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - ------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 11 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 12 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Blackstone Management Associates V L.L.C. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY OWNED BY ------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 10,879,760* WITH ------------------------------------------------------ 9 SOLE DISPOSITIVE POWER -------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON OO - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 13 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 14 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON BMA V L.L.C. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY OWNED BY ------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 10,879,760* WITH ------------------------------------------------------ 9 SOLE DISPOSITIVE POWER -------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON OO - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 15 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 16 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Peter G. Peterson - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY OWNED BY ------------------------------------------------------- EACH 8 SHARED VOTING POWER REPORTING PERSON 10,879,760* WITH ------------------------------------------------------- 9 SOLE DISPOSITIVE POWER ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 17 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 18 CUSIP No. 29256E109 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Stephen A. Schwarzman - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK, OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY OWNED BY -------------------------------------------------------- EACH 8 SHARED VOTING POWER REPORTING PERSON 10,879,760* WITH -------------------------------------------------------- 9 SOLE DISPOSITIVE POWER -------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 10,879,760* - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,879,760* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.3% (See Item 5) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - -------------------------------------------------------------------------------- * Beneficial ownership of the shares of common stock referred to herein is being reported hereunder solely because the reporting person may be deemed to have beneficial ownership of such shares as a result of the Galen Voting Agreement and Management Voting Agreement described in Item 4 hereof. Neither the filing of 19 this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the reporting persons that it is the beneficial owner of any of the shares of common stock referred to herein for purposes of Section 13(d) of the Exchange Act or for any other purpose, and such beneficial ownership is expressly disclaimed. 20 ITEM 1. SECURITY AND ISSUER. This Statement on Schedule 13D (the "Schedule 13D") relates to the shares of common stock, par value $0.001 per share (the "Common Stock") of Encore Medical Corporation, a Delaware corporation (the "Company"). The principal executive offices of the Company are located at 9800 Metric Blvd., Austin, Texas 78758. ITEM 2. IDENTITY AND BACKGROUND. This Schedule 13D is being filed jointly by: (i) Grand Slam Acquisition Corp., a Delaware corporation ("BCP Acquisition"); (ii) Grand Slam Holdings, LLC, a Delaware limited liability company ("BCP Holdings" and, together with BCP Acquisition, the "BCP Acquisition Entities"), the sole equity holder of BCP Acquisition; (iii) Blackstone Capital Partners V L.P., a Delaware limited partnership ("BCP V"), Blackstone Family Investment Partnership V L.P., a Delaware limited partnership ("BFIP"), Blackstone Family Investment Partnership V-A L.P., a Delaware limited partnership ("BFIP-A"), and Blackstone Participation Partnership V L.P., a Delaware limited partnership (together with BCP V, BFIP and BFIP-A the "Blackstone Partnerships"), which collectively own all of the equity in BCP Holdings; (iv) Blackstone Management Associates V L.L.C., a Delaware limited liability company ("BMA"), in its capacity as the general partner of the Blackstone Partnerships; (v) BMA V L.L.C. a Delaware limited liability company ("BMA V"), in its capacity as sole member of BMA; (vi) Mr. Peter G. Peterson; and (vii) Mr. Stephen A. Schwarzman (the foregoing, collectively, the "Reporting Persons"). Each of the BCP Acquisition Entities was formed to effect the transactions described in Item 4 below and has not engaged in any activities other than those incident to its formation and such transactions. The principal business address of BCP Acquisition and BCP Holdings is c/o The Blackstone Group, 345 Park Avenue, New York, New York 10154, Attn: Chinh E. Chu. The principal business of the Blackstone Partnerships is investing in securities and committing capital to facilitate corporate restructurings, leveraged buyouts, bridge financings and other investments. BMA is the sole general partner of the Blackstone Partnerships. The principal business of BMA consists of performing the functions of, and serving as, the sole general partner of the Blackstone Partnerships. BMA V is the sole member of BMA. The principal business of BMA V consists of performing the functions of, and serving as, the sole member of BMA. The principal business address of the Blackstone Partnerships, 21 BMA and BMA V is c/o The Blackstone Group, 345 Park Avenue, New York, New York 10154, Attn: Chinh E. Chu. Messrs. Peter G. Peterson and Stephen A. Schwarzman are the founding members and the controlling persons of BMA V. Each of Messrs. Peterson and Schwarzman is a United States citizen. The principal occupation of each of Messrs. Peterson and Schwarzman is serving as an executive of one or more of the Blackstone Partnerships, BMA and their affiliates. The business address of each of Messrs. Peterson and Schwarzman is c/o The Blackstone Group, 345 Park Avenue, New York, New York 10154. During the last five years, none of the Reporting Persons and, to the best knowledge of the Reporting Persons, none of the persons listed on Schedule I, has been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding has been or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violations of such laws. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. The BCP Acquisition Entities estimate that the total amount of funds required to purchase all of the outstanding Common Stock of the Company pursuant to the transaction referred to in item 4 below, to repay in full all outstanding indebtedness under the Company's existing credit facility and to consummate a tender offer and related consent solicitation with respect to the Company's and its subsidiaries' outstanding senior subordinated notes will be approximately $870.0 million, including related fees and expenses. The BCP Acquisition Entities currently expect that this amount will be funded by approximately $330.0 million in common equity and $540.0 million from the incurrence or issuance of new indebtedness. The BCP Acquisition Entities currently expect such new indebtedness to be provided through (a) the incurrence of $325.0 million of indebtedness under a new senior secured term loan facility (the "Term Facility") and (b) either (i) the incurrence of $215.0 million of indebtedness under a new senior subordinated bridge loan facility (the "Bridge Facility") or (ii) the issuance of $215.0 million of new senior subordinated notes (the "Notes"). The Blackstone Partnerships and their affiliates expect to provide the common equity. The BCP Acquisition Entities have obtained commitments for $540.0 million of indebtedness to be provided by Bank of America, N.A., Bank of America Bridge LLC and Credit Suisse under each of the Term Facility and the Bridge Facility pursuant to a commitment letter, dated June 30, 2006 (the "Commitment Letter"). The Commitment Letter is attached as Exhibit 5 to this Schedule 13D. The BCP Acquisition Entities currently expect that the indebtedness to be incurred under the Term Facility will mature seven years after the date of such incurrence and that the indebtedness, if any, incurred under the Bridge Facility will mature one year after the date of such incurrence and shall automatically be rolled over to new term loans with an additional nine year term. The term of any Notes issued shall be governed by market conditions at the time of issuance. 22 The BCP Acquisition Entities expect that the indebtedness under the Term Facility will accrue interest at a rate per annum based on LIBOR or a base rate plus a spread (the "Term Loan Spread"). The BCP Acquisition Entities currently expect that the Term Loan Spread will be 2.00% for LIBOR loans or 1.00% for base rate loans. The BCP Acquisition Entities expect that the indebtedness under the Bridge Facility will accrue interest at a rate per annum based on LIBOR plus a spread (the "Bridge Spread"). The BCP Acquisition Entities currently expect that the Bridge Spread will initially be 5.50%, subject to an increase of 0.50% on the six month anniversary of the incurrence of such indebtedness and an additional 0.50% increase at the end of each subsequent three-month period, subject to a cap. The BCP Acquisition Entities may refinance the Bridge Facility with the issuance of debt securities, including the Notes. ITEM 4. PURPOSE OF THE TRANSACTION. The response to Item 3 is hereby incorporated by reference. On May 17, 2006, at the request of the Company, BMA, on behalf of BCP V and affiliated funds, submitted a letter to the Company outlining a proposal to acquire the Company in a public to private transaction (the "Transaction"). On June 30, 2006, the Company issued a press release that it had entered into an agreement and plan of merger (the "Merger Agreement") with the BCP Acquisition Entities, pursuant to which, among other things, the Company would become wholly owned by BCP Holdings. The Company entered into the Merger Agreement based on the unanimous recommendation by a special committee comprised of independent directors of the Company's board of directors and the unanimous consent of its full Board of Directors. Concurrently with execution of the Merger Agreement, the BCP Acquisition Entities entered into a voting agreement dated as of June 30, 2006, with Galen Partners III, L.P., Galen Partners International III, L.P., and Galen Employee Fund III, L.P. (each a "Galen Holder", and collectively, the "Galen Holders") (the "Galen Voting Agreement"), relating to the 10,088,724 shares of Common Stock beneficially owned by the Galen Holders or any shares of Common Stock over which any Galen Holder acquires beneficial ownership subsequent to the date of the Galen Voting Agreement (collectively, the "Galen Subject Shares"). Pursuant to the Galen Voting Agreement, and during the Voting Period (as defined below), each Galen Holder has agreed to vote or execute consents with respect to all Galen Subject Shares beneficially owned as of the applicable record date in favor of the approval of the Merger Agreement and the transactions contemplated by the Merger Agreement, at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company at or in connection with which any of such holders vote or execute consents with respect to any of the foregoing matters. In addition, each Galen Holder has also agreed, during the Voting Period, to vote or execute consents, as applicable, with respect to the Galen Subject Shares beneficially owned by it as of the applicable record date (or cause to be voted or a consent to be executed with respect to the Galen Subject Shares beneficially owned by it as of the applicable record date) 23 against each of the matters set forth in clauses (i) or (ii) below at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company at or in connection with which any of such holders vote or execute consents with respect to any of the following matters: (i) any action, proposal, transaction or agreement involving the Company or any of its subsidiaries that would reasonably be expected to, in any material respect, prevent, impede, frustrate, interfere with, delay, postpone or adversely affect the Transaction or the other transactions contemplated by the Merger Agreement; or (ii) any Acquisition Proposal (as defined below), other than an Acquisition Proposal made by BCP Holdings. The Galen Holders have appointed BCP Holdings as their proxy and attorney-in-fact, with full power of substitution and resubstitution, to vote or act by written consent during the Voting Period with respect to the Galen Subject Shares in accordance with the Galen Voting Agreement. In addition, pursuant to the Galen Voting Agreement, the Galen Holders have agreed, during the Voting Period, not to transfer any or all of the Galen Subject Shares beneficially owned by such Galen Holder or deposit any Subject Shares beneficially owned by such Galen Holder in a voting trust or subject any of such Galen Subject Shares beneficially owned by such Galen Holder to any arrangement or agreement with any person (other than BCP Holdings) with respect to the voting or the execution of consents with respect to any such Galen Subject Shares that would reasonably be expected to restrict such Galen Holder's ability to comply with and perform such Galen Holder's covenants and obligations under the Galen Voting Agreement. Concurrently with execution of the Merger Agreement, the BCP Acquisition Entities entered into a voting agreement dated as of June 30, 2006, with Kenneth W. Davidson and Harry L. Zimmerman (each a "Management Holder", and collectively, the "Management Holders") (the "Management Voting Agreement"), relating to the 791,036 shares of Common Stock beneficially owned by the Management Holders or any shares of Common Stock over which any Management Holder acquires beneficial ownership subsequent to the date of the Management Voting Agreement (collectively, the "Management Subject Shares"). Pursuant to the Management Voting Agreement, and during the Voting Period, each Management Holder has agreed to vote or execute consents with respect to all Management Subject Shares beneficially owned as of the applicable record date in favor of the approval of the Merger Agreement and the transactions contemplated by the Merger Agreement, at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company at or in connection with which any of such holders vote or execute consents with respect to any of the foregoing matters. In addition, each Management Holder has also agreed, during the Voting Period, to vote or execute consents, as applicable, with respect to the Management Subject Shares beneficially owned by it as of the applicable record date (or cause to be voted or a consent to be executed with respect to the Management Subject Shares beneficially owned by it as of the applicable record date) against each of the matters set forth in clauses (i) or (ii) below at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company 24 at or in connection with which any of such holders vote or execute consents with respect to any of the following matters: (i) any action, proposal, transaction or agreement involving the Company or any of its subsidiaries that would reasonably be expected to, in any material respect, prevent, impede, frustrate, interfere with, delay, postpone or adversely affect the Transaction or the other transactions contemplated by the Merger Agreement; or (ii) any Acquisition Proposal, other than an Acquisition Proposal made by BCP Holdings. The Management Holders have appointed BCP Holdings as their proxy and attorney-in-fact, with full power of substitution and resubstitution, to vote or act by written consent during the Voting Period with respect to the Management Subject Shares in accordance with the Voting Agreement. Pursuant to the Management Voting Agreement, except for transfers to Permitted Transferees (as defined below), the Management Holders have agreed, during the Voting Period, not to transfer any or all of the Management Subject Shares beneficially owned by such Management Holder or deposit any Management Subject Shares beneficially owned by such Management Holder in a voting trust or subject any of such Management Subject Shares beneficially owned by such Management Holder to any arrangement or agreement with any person (other than BCP Holdings) with respect to the voting or the execution of consents with respect to any such Management Subject Shares that would reasonably be expected to restrict such Management Holder's ability to comply with and perform such Management Holder's covenants and obligations under the Management Voting Agreement. "Voting Period" means the period from and including June 30, 2006 through and including the earlier to occur of (i) the Effective Time of the Transaction (as defined in the Merger Agreement) and (ii) the termination of the Merger Agreement by the BCP Acquisition Entities or the Company in accordance with its terms. "Acquisition Proposal" means any proposal or offer (i) relating to a merger, reorganization, consolidation, dissolution, sale of substantial assets, tender offer, exchange offer, recapitalization, liquidation, dissolution, joint venture, share exchange or other business combination involving the Company or any of its subsidiaries, (ii) for the issuance by the Company of 20% or more of its equity securities or (iii) to acquire in any manner, directly or indirectly, 20% or more of the capital stock or assets of the Company or any of its subsidiaries, in each case other than the transactions contemplated by the Merger Agreement. "Permitted Transferee" means, with respect to any Management Holder, any of the following persons: (i) the spouse of such Management Holder, (ii) the children of such Management Holder, (iii) a trust of which there are no principal beneficiaries other than such Management Holder, such Management Holder's spouse or such Management Holder's children, (iv) upon the death of such Management Holder, the beneficiaries under the terms of any trust or will of the Management Holder or by law of intestate succession, and (v) any charitable foundation or similar charitable organization founded and controlled by such Management Holder or the Management Holder jointly (and which remains under the control of such Management Holder or the Management Holder jointly, as applicable). 25 The consummation of the Transaction will be conditioned upon, among other things: (i) shareholder approval of the Transaction; (ii) the absence of any material adverse effect with respect to the Company; (iii) completion of a tender offer and consent solicitation for all of a Company subsidiary's outstanding 9.75% senior subordinated notes; and (iv) the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Acts of 1976 and the receipt of other antitrust and regulatory approvals. The purpose of the Transaction is to acquire 100% of the equity interest in the Company. Concurrently with consummation of the Transaction, it is contemplated that the Common Stock will be delisted from The NASDAQ National Market and will become eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act. The articles of incorporation and by-laws, as amended, of BCP Acquisition in effect immediately prior to the Effective Time, will be the articles of incorporation and by-laws of the surviving corporation in the Transaction. Additionally, the directors of BCP Acquisition immediately prior to the Effective Time will be the directors of the surviving corporation in the Transaction. Other than as described above and in the Merger Agreement, none of the Reporting Persons or, to the best knowledge of the Reporting Persons, any of the persons listed on Schedule I have any plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D (although they reserve the right to develop such plans or proposals). References to, and descriptions of, the Merger Agreement, the Galen Voting Agreement and the Management Voting Agreement in this Item 4 are qualified in their entirety by this reference to the Merger Agreement, the Galen Voting Agreement and the Management Voting Agreement, copies of which are filed as Exhibits 2, 3 and 4, respectively, to this Schedule 13D and which are incorporated by reference in this Item 4 in their entirety where such references and descriptions appear. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) and (b). The information contained on the cover pages of this Schedule 13D is incorporated herein by reference. For the purpose of Rule 13d-3 promulgated under the Exchange Act, the BCP Acquisition Entities, by entering into the Galen Voting Agreement with the Galen Holders and the Management Voting Agreement with the Management Holders, may be deemed to have shared voting power and/or shared dispositive power with respect to (and therefore beneficially own) 10,879,760 shares of Common Stock, representing approximately 15.3% of the total outstanding Common Stock. The calculation of the foregoing percentage is based on 71,004,134 shares of common stock outstanding as of May 1, 2006, based on the Company's quarterly report on Form 10-Q for the quarterly period ended April 1, 2006 filed with the Securities and Exchange Commission (the "SEC") on May 10, 2006. BCP Holdings, as the sole equity holder of BCP Acquisition has the power to vote and dispose of securities held by BCP Acquisition and may therefore have voting and dispositive 26 power over the shares of Common Stock that BCP Acquisition may be deemed to beneficially own. The Blackstone Partnerships, as the holders of the equity interests in BCP Holdings, have shared power to vote and dispose of securities held by BCP Holdings and may therefore have voting and dispositive power over the shares of Common Stock that BCP Holdings may be deemed to beneficially own. In addition, the Blackstone Partnerships may be deemed to indirectly control BCP Acquisition and have shared voting and dispositive power over the shares of Common Stock that BCP Acquisition may be deemed to beneficially own. BMA, as the general partner of the Blackstone Partnerships, has the power to vote and dispose of securities held by the Blackstone Partnerships. BMA may therefore be deemed to indirectly control BCP Holdings and BCP Acquisition and have shared voting and dispositive power over the shares of Common Stock that BCP Holdings and BCP Acquisition may be deemed to beneficially own. BMA V, as the sole member of BMA, has the power to vote and dispose of securities held by BMA. BMA V may therefore be deemed to indirectly control BCP Holdings and BCP Acquisition and have shared voting and dispositive power over the shares of Common Stock that BCP Holdings and BCP Acquisition may be deemed to beneficially own. Messrs. Peterson and Schwarzman have shared power to vote and dispose of securities held by BMA V, and may therefore be deemed to indirectly control BCP Holdings and BCP Acquisition and have shared voting and dispositive power over the shares of Common Stock that BCP Holdings and BCP Acquisition may be deemed to beneficially own. Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission by any of the Reporting Persons that it is the beneficial owner of any of the shares of Common Stock referred to herein for purposes of Section 13(d) of the Exchange Act, or for any other purpose, and such beneficial ownership is expressly disclaimed. None of the Reporting Persons or, to the best knowledge of the Reporting Persons, none of the persons listed on Schedule I, has beneficial ownership of any shares of Common Stock, except as described in this Schedule 13D. (c) None of the Reporting Persons or, to the best knowledge of the Reporting Persons, none of the persons listed on Schedule I, has engaged in any transaction during the past 60 days in, any shares of Common Stock, except as described in this Schedule 13D. (d) Not applicable. (e) Not applicable. References to, and descriptions of, the Galen Voting Agreement and Management Voting Agreement in this Item 5 are qualified in their entirety by reference to the Galen Voting Agreement and Management Voting Agreement, copies of which are filed as Exhibits 3 and 4 to this Schedule 13D, respectively, and which are incorporated by reference in this Item 5 in their entirety where such references and descriptions appear. 27 ITEM 6. CONTRACTS, ARRANGEMENTS OR UNDERSTANDINGS WITH RESPECT TO SECURITIES OF THE ISSUER. The responses to Items 3, 4 and 5 of this Schedule 13D and Exhibits 2, 3, 4 and 5 are incorporated herein by reference. An affiliate of the Reporting Persons also has agreed to pay customary fees to Credit Suisse Securities (USA) LLC in the event the Transaction is completed. Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), BCP Acquisition will be merged with and into the Company, at which time the separate corporate existence of BCP Acquisition shall cease and the Company shall continue its existence as the surviving corporation (the "Merger"). Upon consummation of the Merger, (i) each share of the common stock, par value $0.01 per share, of BCP Acquisition issued and outstanding immediately prior to the Effective Time shall be converted into and become one fully paid and nonassessable share of common stock, $0.01 par value per share, of the Company; (ii) all shares of Common Stock that are owned by the Company as treasury stock and any shares of Common Stock owned by the BCP Acquisition Entities immediately prior to the Effective Time shall be cancelled and shall cease to exist and no payment shall be made or consideration delivered in respect thereof; and (iii) each share of Common Stock (other than (A) shares to be cancelled (B) shares of Common Stock owned by any wholly-owned subsidiary of the Company, which shall remain outstanding, and (C) dissenting shares issued and outstanding immediately prior to the Effective Time shall be automatically converted as of the Effective Time into the right to receive $6.55 in cash per share, without interest. Except as set forth in this Schedule 13D none of the Reporting Persons and, to the best knowledge of the Reporting Persons, none of the persons listed on Schedule I, have any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to any securities of the Company, including but not limited to, transfer or voting of any of the securities of the Company, finders' fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies, or a pledge or contingency the occurrence of which would give another person voting or investment power over the securities of the Company. References to, and descriptions of, the Merger Agreement in this Item 6 are qualified in their entirety by reference to the Merger Agreement, a copy of which is filed as Exhibit 2 to this Schedule 13D and which is incorporated by reference in this Item 6 in its entirety where such references and descriptions appear. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. 1. Joint Filing Agreement. 2. Agreement and Plan of Merger, dated June 30, 2006, among Grand Slam Holdings, LLC, Grand Slam Acquisition Corp. and Encore Medical Corporation (incorporated by reference to Exhibit 2.1 to Encore Medical Corporation's Report on Form 8-K furnished to the SEC on July 3, 2006, File no. 000-26538). 28 3. Voting Agreement, dated June 30, 2006, among Grand Slam Holdings, LLC, Grand Slam Acquisition Corp., Galen Partners III, L.P., Galen Partners International III, L.P., and Galen Employee Fund III, L.P. 4. Voting Agreement, dated June 30, 2006, among Grand Slam Holdings, LLC, Grand Slam Acquisition Corp., Kenneth W. Davidson and Harry L. Zimmerman. 5. Senior Secured Facilities and Senior Subordinated Bridge Facility Commitment Letter, dated June 30, 2006, among Grand Slam Holdings, LLC, Grand Slam Acquisition Corp., Banc of America Securities LLC, Bank of America, N.A., Bank of America Bridge LLC, Credit Suisse Securities (USA) LLC and Credit Suisse, Cayman Islands Branch. 29 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: July 10, 2006 GRAND SLAM ACQUISITION CORP. By: /s/ Chinh E. Chu ------------------------ Name: Chinh E. Chu Title: President GRAND SLAM HOLDINGS, LLC By: /s/ Chinh E. Chu ------------------------ Name: Chinh E. Chu Title: President BLACKSTONE CAPITAL PARTNERS V L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person BLACKSTONE FAMILY INVESTMENT PARTNERSHIP V L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person 30 BLACKSTONE FAMILY INVESTMENT PARTNERSHIP V-A L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person BLACKSTONE PARTICIPATION PARTNERSHIP V L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ---------------------------- Name: Chinh E. Chu Title: Authorized Person BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C. By: /s/ Chinh E. Chu ---------------------------- Name: Chinh E. Chu Title: Authorized Person BMA V L.L.C. By: /s/ Chinh E. Chu ---------------------------- Name: Chinh E. Chu Title: Senior Managing Director PETER G. PETERSON /s/ Peter G. Peterson ---------------------------- STEPHEN A. SCHWARZMAN /s/ Stephen A. Schwarzman ---------------------------- 31 Schedule I Officers of Grand Slam Holdings, LLC Each of the persons named below is a citizen of the United States. The principal business address of each of the persons named below is 345 Park Avenue, New York, New York 10154. The principal occupation of each of the persons named below is serving as an executive of the Reporting Persons and/or their affiliated entities. Name - ------------ Chinh E. Chu Julia Kahr Directors and Officers of Grand Slam Acquisition Corp. Each of the persons named below is a citizen of the United States. The principal business address of each of the persons named below is 345 Park Avenue, New York, New York 10154. The principal occupation of each of the persons named below is serving as an executive of the Reporting Persons and/or their affiliated entities. Name - ------------- Chinh E. Chu Julia Kahr 32 EX-1 2 exh1_new.txt JOINT FILING AGREEMENT Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) of the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of us of an a Schedule 13D relating to the common stock of Encore Medical Corporation, a Delaware corporation, and that any subsequent amendments thereto filed by any of us will be filed on behalf of each of us. This Agreement may be included as an exhibit to such joint filing. DATE: July 10, 2006 GRAND SLAM ACQUISITION CORP. By: /s/ Chinh E. Chu ----------------------- Name: Chinh E. Chu Title: President GRAND SLAM HOLDINGS, LLC By: /s/ Chinh E. Chu ----------------------- Name: Chinh E. Chu Title: President BLACKSTONE CAPITAL PARTNERS V L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person BLACKSTONE FAMILY INVESTMENT PARTNERSHIP V L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person BLACKSTONE FAMILY INVESTMENT PARTNERSHIP V-A L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person BLACKSTONE PARTICIPATION PARTNERSHIP V L.P. By: Blackstone Management Associates V L.L.C., its General Partner By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Authorized Person BMA V L.L.C. By: /s/ Chinh E. Chu ------------------------- Name: Chinh E. Chu Title: Senior Managing Director PETER G. PETERSON By: /s/ Peter G. Peterson ----------------------------- 2 STEPHEN A. SCHWARZMAN By:/s/ Stephen A. Schwarzman ---------------------------- 3 EX-3 3 exh_3.txt VOTING AGREEMENT Exhibit 3 GALEN VOTING AGREEMENT This VOTING AGREEMENT (this "Agreement") is entered into as of June 30, 2006, by and among Grand Slam Holdings, LLC, a Delaware limited liability company ("Parent"), Grand Slam Acquisition Corp., a Delaware corporation ("Merger Sub"), Galen Partners III, L.P., a Delaware limited partnership ("GP III"), Galen Partners International III, L.P., a Delaware limited partnership ("GP Intl III"), and Galen Employee Fund III, L.P., a Delaware limited partnership ("GEF III") (each of GP III, GP Intl III and GEF III, a "Stockholder" and, together, the "Stockholders"). W I T N E S S E T H: WHEREAS, as of the date of this Agreement, the Stockholders beneficially own, in the aggregate, 10,088,724 shares of Common Stock, par value $0.001 per share (the "Common Stock"), of Encore Medical Corporation, a Delaware corporation (the "Company"); WHEREAS, concurrently herewith, the Company, Parent and Merger Sub are entering into an Agreement and Plan of Merger, dated as of this date, as the same may be amended (the "Merger Agreement"), pursuant to which Merger Sub will merge with and into the Company and the Company will continue its existence as the surviving corporation (the "Merger"), and each share of Common Stock will be converted into the right to receive cash in accordance with the terms of the Merger Agreement; and WHEREAS, as a condition to the willingness of Parent and Merger Sub to enter into the Merger Agreement, and as an inducement and in consideration therefor, Parent and Merger Sub have required that each of the Stockholders agree, and each of the Stockholders has agreed, to enter into this Agreement. NOW, THEREFORE, in consideration of the foregoing and the mutual premises, representations, warranties, covenants and agreements contained in this Agreement, the parties, intending to be legally bound, hereby agree as follows: ARTICLE I DEFINITIONS SECTION 1.1 Defined Terms. For purposes of this Agreement, terms used in this Agreement that are defined in the Merger Agreement but not in this Agreement shall have the respective meanings ascribed to them in the Merger Agreement. SECTION 1.2 Other Definitions. For purposes of this Agreement: (a) "New Shares" means any shares of capital stock of the Company (other than Owned Shares) over which either Stockholder acquires beneficial ownership at any time from and after the date of this Agreement through the termination of the Voting Period. (b) "Owned Shares" means all of the shares of Common Stock beneficially owned by the Stockholders as of the date of this Agreement. The Owned Shares consist of: (i) 9,216,431 shares of Common Stock held by GP III, (ii) 834,204 shares of Common Stock held by GP Intl III and 38,089 shares of Common Stock held by GEF III. In the event of a stock dividend or distribution, or any change in the Common Stock by reason of any stock dividend or distribution, split-up, recapitalization, combination, exchange of shares or the like, the "Owned Shares" shall be deemed to refer to and include the Owned Shares (as defined in the first sentence of this paragraph) as well as all stock dividends and distributions and any securities into which or for which any or all of those Owned Shares may be changed or exchanged or which are received in the transaction. (c) Representative" means, with respect to any particular person, any director, officer, employee, accountant, consultant, legal counsel, investment banker, advisor, agent or other representatives of that person. (d) "Transfer" means sell, transfer, tender, pledge, encumber, hypothecate, assign or otherwise dispose, by operation of law or otherwise. (e) "Voting Period" means the period from and including the date of this Agreement through and including the earlier to occur of (i) the Effective Time and (ii) the termination of the Merger Agreement by Parent or Merger Sub or the Company pursuant to Section 8.1 of the Merger Agreement. ARTICLE II VOTING AGREEMENT AND IRREVOCABLE PROXY SECTION 2.1 Agreement to Vote. (a) Each of the Stockholders hereby agrees that, during the Voting Period, such Stockholder shall vote or execute consents, as applicable, with respect to the Owned Shares and any New Shares beneficially owned by it as of the applicable record date (or cause to be voted or a consent to be executed with respect to the Owned Shares and any New Shares beneficially owned by it as of the applicable record date) in favor of the approval of the Merger Agreement and the transactions contemplated by the Merger Agreement, at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company at or in connection with which any of such holders vote or execute consents with respect to any of the foregoing matters. (b) Each of the Stockholders hereby agrees that, during the Voting Period, such Stockholder shall vote or execute consents, as applicable, with respect to the Owned Shares and any New Shares beneficially owned by it as of the applicable record date (or cause to be voted or a consent to be executed with respect to the Owned Shares and any New Shares beneficially owned by it as of the applicable record date) against each of the matters set forth in clauses (i), (ii) or (iii) below at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company at or in connection with which any of such holders vote or execute consents with respect to any of the following matters: (i) any action, proposal, transaction or agreement involving the Company or any of its subsidiaries that would reasonably be expected to, in any material respect, -2- prevent, impede, frustrate, interfere with, delay, postpone or adversely affect the Merger or the other transactions contemplated by the Merger Agreement; or (ii) any Acquisition Proposal, other than an Acquisition Proposal made by Parent. (c) Any vote required to be cast or consent required to be executed pursuant to this Section 2.1 shall be cast or executed in accordance with the applicable procedures relating thereto so as to ensure that it is duly counted for purposes of determining that a quorum is present (if applicable) and for purposes of recording the results of that vote or consent. (d) Except as set forth in clauses (a) and (b) of this Section 2.1, no Stockholder shall be restricted from voting in favor of, against or abstaining with respect to any matter presented to the stockholders of the Company. In addition, nothing in this Agreement shall give Parent the right to vote any Owned Shares at any meeting of the stockholders other than as provided in this Section 2.1. SECTION 2.2 Grant of Irrevocable Proxy. Each of the Stockholders hereby irrevocably appoints Parent as such Stockholder's proxy and attorney-in-fact, with full power of substitution and resubstitution, to vote or execute consents during the Voting Period, with respect to the Owned Shares and any New Shares beneficially owned by such Stockholder, solely in respect of the matters described in, and in accordance with, Section 2.1. This proxy is given to secure the performance of the duties of such Stockholder under this Agreement. None of the Stockholders shall directly or indirectly grant any person any proxy (revocable or irrevocable), power of attorney or other authorization with respect to any of the Owned Shares or New Shares that is inconsistent with Sections 2.1 and 2.2. SECTION 2.3 Nature of Irrevocable Proxy. The proxy and power of attorney granted pursuant to Section 2.2 by each of the Stockholders shall be irrevocable during the Voting Period, shall be deemed to be coupled with an interest sufficient in law to support an irrevocable proxy and shall revoke any and all prior proxies granted by such Stockholder, and such Stockholder acknowledges that the proxy constitutes an inducement for Parent and Merger Sub to enter into the Merger Agreement. The power of attorney granted by each of the Stockholders is a durable power of attorney and shall survive the bankruptcy, death or incapacity of such Stockholder. The proxy and power of attorney granted hereunder shall terminate automatically at the expiration of the Voting Period. ARTICLE III COVENANTS SECTION 3.1 Transfer Restrictions. Each of the Stockholders agrees that such Stockholder shall not, and shall not permit any person, directly or indirectly, to: (a) Transfer any or all of the Owned Shares or New Shares beneficially owned by such Stockholder; provided that the foregoing shall not prevent the conversion of such Owned Shares and New Shares into the right to receive Merger Consideration pursuant to the Merger in accordance with the terms of the Merger Agreement; or -3- (b) deposit any Owned Shares or New Shares beneficially owned by such Stockholder in a voting trust or subject any of such Owned Shares or New Shares beneficially owned by such Stockholder to any arrangement or agreement with any person (other than Parent) with respect to the voting or the execution of consents with respect to any such Owned Shares or New Shares that would reasonably be expected to restrict such Stockholder's ability to comply with and perform such Stockholder's covenants and obligations under this Agreement. SECTION 3.2 No Shop Obligations of the Stockholder. Each Stockholder covenants and agrees with Parent that, during the Voting Period, such Stockholder shall not and shall not authorize any of such Stockholder's Representatives to, directly or indirectly, (i) initiate, solicit, encourage, or knowingly facilitate any inquiry, proposal or offer, or the making, submission or reaffirmation of any inquiry, proposal or offer (including any proposal or offer to the Company's stockholders), that constitutes or would reasonably be expected to lead to any Acquisition Proposal, or (ii) engage in any discussions or negotiations concerning an Acquisition Proposal. Notwithstanding the foregoing, nothing in this Agreement shall limit, restrict or otherwise affect the actions taken in compliance with the Merger Agreement by any Affiliate of any Stockholder in his capacity as a member of the Board of Directors of the Company or any committee thereof. ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS Each of the Stockholders hereby, severally but not jointly, represents and warrants to Parent and Merger Sub as follows: SECTION 4.1 Authorization. Such Stockholder has all legal capacity, power and authority to execute and deliver this Agreement and to perform its obligations hereunder. This Agreement has been duly executed and delivered by such Stockholder and constitutes a legal, valid and binding obligation of such Stockholder, enforceable against such Stockholder in accordance with its terms. SECTION 4.2 Ownership of Shares. Such Stockholder is the sole beneficial owner of all of such Stockholder's Owned Shares and has, or will have at the time of any vote with respect to the matters contemplated by Article II, the sole power to vote (or cause to be voted or consents to be executed) and to dispose of (or cause to be disposed of) all of such Owned Shares. Such Stockholder does not own or hold any right to acquire any additional shares of any class of capital stock of the Company or other securities of the Company or any interest therein or any voting rights with respect to any securities of the Company. None of such Stockholder's Owned Shares are subject to any voting trust agreement or other contract, agreement, arrangement, commitment or understanding to which such Stockholder is a party restricting or otherwise relating to the voting or Transfer of such Stockholder's Owned Shares. Such Stockholder has good and valid title to such Stockholder's Owned Shares, free and clear of any and all Liens. SECTION 4.3 No Conflicts. Except (a) for a filing of an amendment to a Schedule 13D or Schedule 13G, and (b) for a filing of a Form 4 or Form 5 as required by the Exchange Act, (i) no filing with any Governmental Entity, and no authorization, consent or approval of any other person is necessary for the execution of this Agreement by such Stockholder or the performance by such Stockholder of its obligations hereunder and (ii) none of the execution and -4- delivery of this Agreement by such Stockholder or the performance by such Stockholder of its obligations hereunder shall (A) result in, give rise to or constitute a violation or breach of or a default (or any event which with notice or lapse of time or both would become a violation, breach or default) under any of the terms of any agreement or other instrument to which such Stockholder is a party or by which such Stockholder or any of such Stockholder's Owned Shares is bound, or (B) violate any applicable law, rule, regulation, order, judgment, or decree applicable to such Stockholder, except for any of the foregoing as could not reasonably be expected to impair such Stockholder's ability to perform its obligations under this Agreement in any material respect. SECTION 4.4 Reliance by Parent and Merger Sub. Such Stockholder understands and acknowledges that Parent and Merger Sub are entering into the Merger Agreement in reliance upon the execution and delivery of this Agreement by such Stockholder and the agreement by such Stockholder herein to perform such Stockholder's obligations hereunder and comply with the terms hereof. ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB Each of Parent and Merger Sub hereby represent and warrant to each of the Stockholders that (i) it has all legal capacity, power and authority to execute and deliver this Agreement and to perform its obligations hereunder and (ii) this Agreement has been duly executed and delivered by it and constitutes a legal, valid and binding obligation of the party, enforceable against it in accordance with the terms of this Agreement. ARTICLE VI TERMINATION This Agreement shall terminate upon the expiration of the Voting Period; provided that Sections 7.6 through 7.11 and Sections 7.13 through 7.15 shall survive termination of this Agreement. Notwithstanding the foregoing, termination of this Agreement shall not prevent any party from seeking any remedies (at law or in equity) against any other party for that party's breach of any of the terms of this Agreement prior to the date of termination. ARTICLE VII MISCELLANEOUS SECTION 7.1 Appraisal Rights. Each of the Stockholders hereby waives any rights of appraisal or rights to dissent from the Merger or the approval of the Merger Agreement that such Stockholder may have under applicable law and shall not permit any such rights of appraisal or rights of dissent to be exercised with respect to any Owned Shares or any New Shares. SECTION 7.2 Non-Survival of Representations and Warranties. The respective representations and warranties of the Stockholders, Parent and Merger Sub shall not survive the closing of the transactions contemplated hereby and by the Merger Agreement. -5- SECTION 7.3 Further Actions. Each of the Stockholders agrees that such Stockholder shall take any further action and execute any other documents or instruments as may be necessary to effectuate the intent of this Agreement. SECTION 7.4 Fees and Expenses. Except as otherwise expressly set forth in this Agreement, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring the cost or expense whether or not the Merger is consummated. SECTION 7.5 Amendments, Waivers, etc. This Agreement may be amended by the parties at any time. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties. Any party hereto may (i) extend the time for the performance of any of the obligations or other acts of the other parties hereto, (ii) waive any inaccuracies in the representations and warranties contained herein or in any document delivered pursuant hereto and (iii) subject to the requirements of applicable law, waive compliance with any of the agreements or conditions contained herein. Any such extension or waiver shall be valid if set forth in an instrument in writing signed by the party or parties to be bound thereby. The failure of any party to assert any rights or remedies shall not constitute a waiver of such rights or remedies. SECTION 7.6 Notices. All notices, requests, claims, instructions, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by facsimile (provided that the facsimile is promptly confirmed by telephone confirmation thereof) or by overnight courier to the respective parties at the following addresses (or at such other address for a party as shall be specified by like notice): (a) If to the Stockholders, addressed to: c/o Galen Partners III, L.P. 610 Fifth Avenue New York, New York 10020 Attention: Zubeen Shroff Telecopy: (212) 218-4999 with a copy (which shall not constitute notice) to: Ropes & Gray LLP 45 Rockefeller Plaza New York, New York 10111 Attention: Merrill A. Ulmer Telecopy: (212) 841-5725 (b) if to Parent or Merger Sub, addressed to: Blackstone Capital Partners V L.P. c/o The Blackstone Group 345 Park Avenue -6- New York, New York 10154 Attention: Chinh E. Chu Telecopy: 212-583-5712 with a copy to (which shall not constitute notice): Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, New York 10017 Attention: William R. Dougherty, Esq. Telecopy: 212-455-2502 or to that other address as any party shall specify by written notice so given, and notice shall be deemed to have been delivered as of the date so telecommunicated or personally delivered. SECTION 7.7 Headings; Titles. Headings and titles of the Articles and Sections of this Agreement are for the convenience of the parties only, and shall be given no substantive or interpretative effect whatsoever. SECTION 7.8 Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the fullest extent possible. SECTION 7.9 Entire Agreement. This Agreement (together with the Merger Agreement, to the extent referred to in this Agreement) and any documents delivered by the parties in connection herewith constitute the entire agreement among the parties with respect to the subject matter of this Agreement and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof. SECTION 7.10 Assignment; Binding Effect; No Third Party Beneficiaries; Further Action. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of the other parties, except that each of Parent and/or Merger Sub may assign, in its sole discretion, any or all of its rights, interests and obligations under this Agreement to any Affiliate of Blackstone Capital Partners V. L.P. This Agreement shall be binding upon and shall inure to the benefit of Parent and Merger Sub and their respective successors and assigns and shall be binding upon the Stockholders and their respective heirs, executors and administrators. This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person (other than, in the case of Parent and Merger Sub, their respective successors and assigns -7- and, in the case of the Stockholders, their respective heirs, executors and administrators) any rights, benefits or remedies of any nature whatsoever under or by reason of this Agreement. SECTION 7.11 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. Each of the parties hereto (i) consents to submit itself to the personal jurisdiction of the United States District Court for the Southern District of New York or any court of the State of New York located in such district in the event any dispute arises out of this Agreement or any of the transactions contemplated by this Agreement, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction or venue by motion or other request for leave from any such court and (iii) agrees that it will not bring any action relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than such courts sitting in the State of New York. SECTION 7.12 Enforcement of Agreement; Specific Performance. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that Parent and Merger Sub shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the state courts of the State of New York sitting in the City of New York or any court of the United States located in the City of New York, this being in addition to any other remedy to which such party is entitled at law or in equity. The parties agree that the Stockholders shall not be entitled to an injunction or injunctions to prevent any breach of this Agreement by any of Parent or Merger Sub or to enforce specifically any term or any provision of this Agreement. SECTION 7.13 Counterparts; Facsimiles. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. This Agreement or any counterpart may be executed and delivered by facsimile copies, each of which shall be deemed an original. SECTION 7.14 WAIVER OF JURY TRIAL. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. SECTION 7.15 Merger Agreement. The obligations of the Stockholders hereunder are subject to the absence of any change (by amendment or waiver) to the Merger Agreement which is materially adverse, directly or indirectly, to the Stockholders, including but not limited to: (i) any change which decreases the Merger Consideration; or (ii) any change to the form of Merger Consideration (other than the addition of consideration payable in any form). [Signature page follows] -8- IN WITNESS WHEREOF, Parent, Merger Sub and the Stockholders have caused this Agreement to be duly executed as of the day and year first above written. GRAND SLAM HOLDINGS, LLC By: /s/ Chinh E. Chu -------------------------- Name: Chinh E. Chu Title: President GRAND SLAM ACQUISITION CORP. By: /s/ Chinh E. Chu -------------------------- Name: Chinh E. Chu Title: President GALEN PARTNERS III, L.P. By: Claudius, L.L.C., its General Partner By: /s/ Bruce F. Wesson -------------------------- Name: Bruce F. Wesson Title: Member GALEN PARTNERS INTERNATIONAL III, L.P. By: Claudius, L.L.C., its General Partner By: /s/ Bruce F. Wesson -------------------------- Name: Bruce F. Wesson Title: Member GALEN EMPLOYEE FUND III, L.P. By: Wesson Enterprises, Inc., its General Partner By: /s/ Bruce F. Wesson -------------------------- Name: Bruce F. Wesson Title: President [Galen Voting Agreement Signature Page] EX-4 4 exh_4.txt MANAGEMENT VOTING AGREEMENT Exhibit 4 MANAGEMENT VOTING AGREEMENT This VOTING AGREEMENT (this "Agreement") is entered into as of June 30, 2006, by and among Grand Slam Holdings, LLC, a Delaware limited liability company ("Parent"), Grand Slam Acquisition Corp., a Delaware corporation ("Merger Sub"), Kenneth W. Davidson and Harry L. Zimmerman (each, a "Stockholder" and, together, the "Stockholders"). W I T N E S S E T H: WHEREAS, as of the date of this Agreement, the Stockholders beneficially own, in the aggregate, 791,036 shares of Common Stock, par value $0.001 per share (the "Common Stock"), of Encore Medical Corporation, a Delaware corporation (the "Company"); WHEREAS, concurrently herewith, the Company, Parent and Merger Sub are entering into an Agreement and Plan of Merger, dated as of this date, as the same may be amended (the "Merger Agreement"), pursuant to which Merger Sub will merge with and into the Company and the Company will continue its existence as the surviving corporation (the "Merger"), and each share of Common Stock will be converted into the right to receive cash in accordance with the terms of the Merger Agreement; and WHEREAS, as a condition to the willingness of Parent and Merger Sub to enter into the Merger Agreement, and as an inducement and in consideration therefor, Parent and Merger Sub have required that each of the Stockholders agree, and each of the Stockholders has agreed, to enter into this Agreement. NOW, THEREFORE, in consideration of the foregoing and the mutual premises, representations, warranties, covenants and agreements contained in this Agreement, the parties, intending to be legally bound, hereby agree as follows: ARTICLE I DEFINITIONS SECTION 1.1 Defined Terms. For purposes of this Agreement, terms used in this Agreement that are defined in the Merger Agreement but not in this Agreement shall have the respective meanings ascribed to them in the Merger Agreement. SECTION 1.2 Other Definitions. For purposes of this Agreement: (a) "Company Options" means options to acquire Common Stock granted to the Stockholders by the Company. (b) "New Shares" means any shares of capital stock of the Company (other than Owned Shares) over which the Stockholders acquire beneficial ownership at any time from and after the date of this Agreement through the termination of the Voting Period (including Option Shares). (c) "Option Shares" means any shares of Common Stock issued or issuable upon the exercise of Company Options. (d) "Owned Shares" means all of the shares of Common Stock beneficially owned by the Stockholders as of the date of this Agreement. The Owned Shares consist of: (i) 568,887 shares of Common Stock held Kenneth W. Davidson and (ii) 222,149 shares of Common Stock held by Harry L. Zimmerman. In the event of a stock dividend or distribution, or any change in the Common Stock by reason of any stock dividend or distribution, split-up, recapitalization, combination, exchange of shares or the like, the "Owned Shares" shall be deemed to refer to and include the Owned Shares (as defined in the first sentence of this paragraph) as well as all stock dividends and distributions and any securities into which or for which any or all of those Owned Shares may be changed or exchanged or which are received in the transaction. (e) "Permitted Transferee" means, with respect to any Stockholder, any of the following persons: (i) the spouse of such Stockholder, (ii) the children of such Stockholder, (iii) a trust of which there are no principal beneficiaries other than such Stockholder, such Stockholder's spouse or such Stockholder's children, (iv) upon the death of such Stockholder, the beneficiaries under the terms of any trust or will of the Stockholder or by law of intestate succession, and (v) any charitable foundation or similar charitable organization founded and controlled by such Stockholder or the Stockholders jointly (and which remains under the control of such Stockholder or the Stockholders jointly, as applicable). (f) "Representative" means, with respect to any particular person, any director, officer, employee, accountant, consultant, legal counsel, investment banker, advisor, agent or other representatives of that person. (g) "Transfer" means sell, transfer, tender, pledge, encumber, hypothecate, assign or otherwise dispose, by operation of law or otherwise. For purposes of this Agreement, the Transfer of any Company Option shall be deemed a Transfer of the shares issuable upon the exercise thereof. (h) "Voting Period" means the period from and including the date of this Agreement through and including the earlier to occur of (i) the Effective Time and (ii) the termination of the Merger Agreement by Parent or Merger Sub or the Company pursuant to Section 8.1 of the Merger Agreement. ARTICLE II VOTING AGREEMENT AND IRREVOCABLE PROXY SECTION 2.1 Agreement to Vote. (a) Each of the Stockholders hereby agrees that, during the Voting Period, such Stockholder shall vote or execute consents, as applicable, with respect to the Owned Shares and any New Shares beneficially owned by him as of the applicable record date (or cause to be voted or a consent to be executed with respect to the Owned Shares and any New Shares beneficially owned by him as of the applicable record date) in favor of the approval of the Merger Agreement and the transactions contemplated by the Merger Agreement, at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company at or in connection with which any of such holders vote or execute consents with respect to any of the foregoing matters. -2- (b) Each of the Stockholders hereby agrees that, during the Voting Period, such Stockholder shall vote or execute consents, as applicable, with respect to the Owned Shares and any New Shares beneficially owned by him as of the applicable record date (or cause to be voted or a consent to be executed with respect to the Owned Shares and any New Shares beneficially owned by him as of the applicable record date) against each of the matters set forth in clauses (i), (ii) or (iii) below at any meeting (or any adjournment or postponement thereof) of, or in connection with any proposed action by written consent of, the holders of any class or classes of capital stock of the Company at or in connection with which any of such holders vote or execute consents with respect to any of the following matters: (i) any action, proposal, transaction or agreement involving the Company or any of its subsidiaries that would reasonably be expected to, in any material respect, prevent, impede, frustrate, interfere with, delay, postpone or adversely affect the Merger or the other transactions contemplated by the Merger Agreement; or (ii) any Acquisition Proposal, other than an Acquisition Proposal made by Parent. (c) Any vote required to be cast or consent required to be executed pursuant to this Section 2.1 shall be cast or executed in accordance with the applicable procedures relating thereto so as to ensure that it is duly counted for purposes of determining that a quorum is present (if applicable) and for purposes of recording the results of that vote or consent. Nothing contained in this Section 2.1 shall require the Stockholders to vote or execute any consent with respect to any Option Shares on or not issued upon the exercise of a Company Option on or prior to the applicable record date for that vote or consent. (d) Except as set forth in clauses (a) and (b) of this Section 2.1, no Stockholder shall be restricted from voting in favor of, against or abstaining with respect to any matter presented to the stockholders of the Company. In addition, nothing in this Agreement shall give Parent the right to vote any Owned Shares at any meeting of the stockholders other than as provided in this Section 2.1. SECTION 2.2 Grant of Irrevocable Proxy. Each Stockholder hereby irrevocably appoints Parent as such Stockholder's proxy and attorney-in-fact, with full power of substitution and resubstitution, to vote or execute consents during the Voting Period, with respect to the Owned Shares and any New Shares beneficially owned by such Stockholder, solely in respect of the matters described in, and in accordance with, Section 2.1. This proxy is given to secure the performance of the duties of such Stockholder under this Agreement. None of the Stockholders shall directly or indirectly grant any person any proxy (revocable or irrevocable), power of attorney or other authorization with respect to any of the Owned Shares or New Shares that is inconsistent with Sections 2.1 and 2.2. SECTION 2.3 Nature of Irrevocable Proxy. The proxy and power of attorney granted pursuant to Section 2.2 by each of the Stockholders shall be irrevocable during the Voting Period, shall be deemed to be coupled with an interest sufficient in law to support an irrevocable proxy and shall revoke any and all prior proxies granted by such Stockholder, and such Stockholder acknowledges that the proxy constitutes an inducement for Parent and Merger Sub -3- to enter into the Merger Agreement. The power of attorney granted by each of the Stockholders is a durable power of attorney and shall survive the bankruptcy, death or incapacity of such Stockholder. The proxy and power of attorney granted hereunder shall terminate automatically at the expiration of the Voting Period. ARTICLE III COVENANTS SECTION 3.1 Transfer Restrictions. Each of the Stockholders agrees that such Stockholder shall not, and shall not permit any person, directly or indirectly, to: (a) Transfer any or all of the Owned Shares or New Shares beneficially owned by such Stockholder; provided that the foregoing shall not prevent (i) the Transfer of Owned Shares or New Shares to any Permitted Transferee who executes and delivers to Parent an agreement to be bound by the terms of this Agreement to the same extent as such Stockholder, or (ii) the conversion of such Owned Shares and New Shares into the right to receive Merger Consideration pursuant to the Merger in accordance with the terms of the Merger Agreement; or (b) deposit any Owned Shares or New Shares beneficially owned by such Stockholder in a voting trust or subject any of such Owned Shares or New Shares beneficially owned by such Stockholder to any arrangement or agreement with any person (other than Parent) with respect to the voting or the execution of consents with respect to any such Owned Shares or New Shares that would reasonably be expected to restrict such Stockholder's ability to comply with and perform such Stockholder's covenants and obligations under this Agreement. SECTION 3.2 No Shop Obligations of the Stockholder. Subject to Section 3.3, each of the Stockholders covenants and agrees with Parent that, during the Voting Period, such Stockholder shall not and shall not authorize any of such Stockholder's Representatives to, directly or indirectly, (i) initiate, solicit, encourage, or knowingly facilitate any inquiry, proposal or offer, or the making, submission or reaffirmation of any inquiry, proposal or offer (including any proposal or offer to the Company's stockholders), that constitutes or would reasonably be expected to lead to any Acquisition Proposal, or (ii) engage in any discussions or negotiations concerning an Acquisition Proposal. Notwithstanding the foregoing, nothing in this Agreement shall limit, restrict or otherwise affect the actions taken in compliance with the Merger Agreement by any Affiliate of any Stockholder in his capacity, as applicable, as a member of the Board of Directors of the Company or any committee thereof. SECTION 3.3 Stockholder's Capacity. Parent and Merger Sub acknowledge that each of the Stockholders is not making any agreement or understanding herein in his capacity as a director or officer of the Company and that the Stockholder is executing this agreement solely in his capacity as the beneficial owner of Common Stock and nothing herein shall limit or affect any actions taken by the Stockholder in his capacity as a director or officer of the Company. Nothing herein shall limit or affect the Company's rights in connection with the Merger Agreement. -4- ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS Each Stockholder hereby, severally but not jointly, represents and warrants to Parent and Merger Sub as follows: SECTION 4.1 Authorization. Such Stockholder has all legal capacity, power and authority to execute and deliver this Agreement and to perform his obligations hereunder. This Agreement has been duly executed and delivered by such Stockholder and constitutes a legal, valid and binding obligation of such Stockholder, enforceable against such Stockholder in accordance with its terms. SECTION 4.2 Ownership of Shares. Such Stockholder is the sole beneficial owner of all of such Stockholder's Owned Shares and Option Shares and has, or will have at the time of any vote with respect to the matters contemplated by Article II, the sole power to vote (or cause to be voted or consents to be executed) and to dispose of (or cause to be disposed of) all of such Owned Shares and, upon their issuance, Option Shares. Such Stockholder does not own or hold any right to acquire any additional shares of any class of capital stock of the Company or other securities of the Company or any interest therein or any voting rights with respect to any securities of the Company. None of such Stockholder's Owned Shares and Option Shares are subject to any voting trust agreement or other contract, agreement, arrangement, commitment or understanding to which such Stockholder is a party restricting or otherwise relating to the voting or Transfer of such Stockholder's Owned Shares or Option Shares. Such Stockholder has good and valid title to such Stockholder's Owned Shares and Company Options, free and clear of any and all Liens. SECTION 4.3 No Conflicts. Except (a) for a filing of an amendment to a Schedule 13D or Schedule 13G, and (b) for a filing of a Form 4 or Form 5 as required by the Exchange Act, (i) no filing with any Governmental Entity, and no authorization, consent or approval of any other person is necessary for the execution of this Agreement by such Stockholder or the performance by such Stockholder of its obligations hereunder and (ii) none of the execution and delivery of this Agreement by such Stockholder or the performance by such Stockholder of its obligations hereunder shall (A) result in, give rise to or constitute a violation or breach of or a default (or any event which with notice or lapse of time or both would become a violation, breach or default) under any of the terms of any agreement or other instrument to which such Stockholder is a party or by which such Stockholder or any of such Stockholder's Owned Shares is bound, or (B) violate any applicable law, rule, regulation, order, judgment, or decree applicable to such Stockholder, except for any of the foregoing as could not reasonably be expected to impair such Stockholder's ability to perform his obligations under this Agreement in any material respect. SECTION 4.4 Reliance by Parent and Merger Sub. Such Stockholder understands and acknowledges that Parent and Merger Sub are entering into the Merger Agreement in reliance upon the execution and delivery of this Agreement by such Stockholder and the agreement by such Stockholder herein to perform such Stockholder's obligations hereunder and comply with the terms hereof. -5- ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB Each of Parent and Merger Sub hereby represent and warrant to each of the Stockholder that (i) it has all legal capacity, power and authority to execute and deliver this Agreement and to perform his obligations hereunder and (ii) this Agreement has been duly executed and delivered by it and constitutes a legal, valid and binding obligation of the party, enforceable against it in accordance with the terms of this Agreement. ARTICLE VI TERMINATION This Agreement shall terminate upon the expiration of the Voting Period; provided that Sections 7.6 through 7.11 and Section 7.13 through 7.15 shall survive termination of this Agreement. Notwithstanding the foregoing, termination of this Agreement shall not prevent any party from seeking any remedies (at law or in equity) against any other party for that party's breach of any of the terms of this Agreement prior to the date of termination. ARTICLE VII MISCELLANEOUS SECTION 7.1 Appraisal Rights. Each Stockholder hereby waives any rights of appraisal or rights to dissent from the Merger or the approval of the Merger Agreement that such Stockholder may have under applicable law and shall not permit any such rights of appraisal or rights of dissent to be exercised with respect to any Owned Shares or any New Shares. SECTION 7.2 Non-Survival of Representations and Warranties. The respective representations and warranties of the Stockholders, Parent and Merger Sub shall not survive the closing of the transactions contemplated hereby and by the Merger Agreement. SECTION 7.3 Further Actions. Each Stockholder agrees that such Stockholder shall take any further action and execute any other documents or instruments as may be necessary to effectuate the intent of this Agreement. SECTION 7.4 Fees and Expenses. Except as otherwise expressly set forth in this Agreement, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring the cost or expense whether or not the Merger is consummated. SECTION 7.5 Amendments, Waivers, etc. This Agreement may be amended by the parties at any time. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties. Any party hereto may (i) extend the time for the performance of any of the obligations or other acts of the other parties hereto, (ii) waive any inaccuracies in the representations and warranties contained herein or in any document delivered pursuant hereto and (iii) subject to the requirements of applicable law, waive compliance with any of the agreements or conditions contained herein. Any such extension or waiver shall be valid if set forth in an instrument in writing signed by the party or parties to be bound thereby. -6- The failure of any party to assert any rights or remedies shall not constitute a waiver of such rights or remedies. SECTION 7.6 Notices. All notices, requests, claims, instructions, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by facsimile (provided that the facsimile is promptly confirmed by telephone confirmation thereof) or by overnight courier to the respective parties at the following addresses (or at such other address for a party as shall be specified by like notice): (a) If to the Stockholders, addressed to: c/o Grand Slam Corporation 9800 Metric Blvd. Austin, Texas 78758 Attn: Harry L. Zimmerman, Esq. Telecopy: (512) 834-6300 with a copy (which shall not constitute notice) to: Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, New York 10019 Attention: David E. Rubinsky, Esq. Telecopy: (212) 728-8111 (b) if to Parent or Merger Sub, addressed to: Blackstone Capital Partners V L.P. c/o The Blackstone Group 345 Park Avenue New York, New York 10154 Attention: Chinh E. Chu Telecopy: 212-583-5712 with a copy to (which shall not constitute notice): Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, New York 10017 Attention: William R. Dougherty, Esq. Telecopy: 212-455-2502 or to that other address as any party shall specify by written notice so given, and notice shall be deemed to have been delivered as of the date so telecommunicated or personally delivered. -7- SECTION 7.7 Headings; Titles. Headings and titles of the Articles and Sections of this Agreement are for the convenience of the parties only, and shall be given no substantive or interpretative effect whatsoever. SECTION 7.8 Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the fullest extent possible. SECTION 7.9 Entire Agreement. This Agreement (together with the Merger Agreement, to the extent referred to in this Agreement) and any documents delivered by the parties in connection herewith constitute the entire agreement among the parties with respect to the subject matter of this Agreement and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof. SECTION 7.10 Assignment; Binding Effect; No Third Party Beneficiaries; Further Action. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of the other parties, except that each of Parent and/or Merger Sub may assign, in its sole discretion, any or all of its rights, interests and obligations under this Agreement to any Affiliate of Blackstone Capital Partners V. L.P. This Agreement shall be binding upon and shall inure to the benefit of Parent and Merger Sub and their respective successors and assigns and shall be binding upon the Stockholders and their respective heirs, executors and administrators. This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person (other than, in the case of Parent and Merger Sub, their respective successors and assigns and, in the case of the Stockholders, their respective heirs, executors and administrators) any rights, benefits or remedies of any nature whatsoever under or by reason of this Agreement. SECTION 7.11 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. Each of the parties hereto (i) consents to submit itself to the personal jurisdiction of the United States District Court for the Southern District of New York or any court of the State of New York located in such district in the event any dispute arises out of this Agreement or any of the transactions contemplated by this Agreement, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction or venue by motion or other request for leave from any such court and (iii) agrees that it will not bring any action relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than such courts sitting in the State of New York. SECTION 7.12 Enforcement of Agreement; Specific Performance. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is -8- accordingly agreed that Parent and Merger Sub shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the state courts of the State of New York sitting in the City of New York or any court of the United States located in the City of New York, this being in addition to any other remedy to which such party is entitled at law or in equity. The parties agree that the Stockholders shall not be entitled to an injunction or injunctions to prevent any breach of this Agreement by any of Parent or Merger Sub or to enforce specifically any term or any provision of this Agreement. SECTION 7.13 Counterparts; Facsimiles. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. This Agreement or any counterpart may be executed and delivered by facsimile copies, each of which shall be deemed an original. SECTION 7.14 WAIVER OF JURY TRIAL. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. SECTION 7.15 Merger Agreement. The obligations of the Stockholders hereunder are subject to the absence of any change (by amendment or waiver) to the Merger Agreement which is materially adverse, directly or indirectly, to the Stockholders, including but not limited to: (i) any change which decreases the Merger Consideration; or (ii) any change to the form of Merger Consideration (other than the addition of consideration payable in any form). [Signature page follows.] -9- IN WITNESS WHEREOF, Parent, Merger Sub and the Stockholders have caused this Agreement to be duly executed as of the day and year first above written. GRAND SLAM HOLDINGS, LLC By: /s/ Chinh E. Chu -------------------------- Name: Chinh E. Chu Title: President GRAND SLAM ACQUISITION CORP. By: /s/ Chinh E. Chu -------------------------- Name: Chinh E. Chu Title: President KENNETH W. DAVIDSON By: /s/ Kenneth W. Davidson -------------------------- Name: Kenneth W. Davidson Title: Chief Executive Officer HARRY L. ZIMMERMAN By: /s/ Harry L. Zimmerman -------------------------- Name: Harry L. Zimmerman Title: Senior Vice President and General Counsel [Management Voting Agreement Signature Page] EX-5 5 exh_5.txt COMMITMENT LETTER Exhibit 5 EXECUTION VERSION BANK OF AMERICA, N.A. BANC OF AMERICA SECURITIES LLC 100 NORTH TRYON STREET BANC OF AMERICA BRIDGE LLC CHARLOTTE, NORTH CAROLINA 28255 9 WEST 57th STREET NEW YORK, NEW YORK 10019 CREDIT SUISSE CREDIT SUISSE SECURITIES (USA) LLC ELEVEN MADISON AVENUE NEW YORK, NY 10010 June 30, 2006 Grand Slam Holdings, LLC c/o The Blackstone Group 345 Park Avenue New York, New York 10154 Attention: Mr. Chinh E. Chu Project Grand Slam Commitment Letter $375 Million Senior Secured Credit Facilities; $215 Million Senior Subordinated Bridge Facility Ladies and Gentlemen: You have informed us that the Blackstone Group and its affiliates (the "Sponsor") intend to form a corporation or limited liability company ("Holdings") that intends through a newly formed and wholly-owned subsidiary ("Mergeco") to enter into an agreement and plan of merger and related definitive documentation (collectively, the "Merger Agreement") with a company which the Sponsor has previously identified to the Joint Lead Arrangers (as defined below) (such previously identified company, the "Company") pursuant to which Mergeco will be merged with the Company (the "Merger") in accordance with the terms thereof and will acquire the Company from the existing shareholders of the Company (the "Sellers"), with the Company continuing as the surviving corporation and a subsidiary of Holdings. Concurrently with the consummation of the Merger, the Company will or will cause its subsidiaries to (i) repay in full all outstanding indebtedness under its and one of its subsidiary's (the "Financing Sub") existing senior secured credit agreement agented by Bank of America, N.A. (the "Existing Credit Agreement") and concurrently terminate all commitments thereunder, and (ii) consummate a tender offer and related consent solicitation substantially on the terms set forth on a schedule to the Merger Agreement (the "Tender Offer and Consent Solicitation" and, together with the transactions contemplated in preceding clause (ii), the "Refinancing") with respect to the Financing Sub's outstanding 9 3/4% senior subordinated notes due 2012 (the "Existing Subordinated Notes"). As part of the Tender Offer and Consent Solicitation, (x) the Company or the Financing Sub would offer to purchase any and all of the Existing Subordinated Notes, subject to satisfaction of the Minimum Consent Condition referenced below, and (y) if the Minimum Consent Condition is satisfied and the Existing Subordinated Notes are accepted for purchase pursuant to the Tender Offer and Consent Solicitation, consents will be obtained for amendments to the indenture governing the Existing Subordinated Notes (the "Existing Subordinated Notes Indenture"), and supplements to such indenture will be effectuated, which would substantially eliminate the negative covenants applicable thereto, except those requiring the consent of all noteholders affected by such changes as set forth in the schedule to the Merger Agreement. As used herein, the term "Minimum Consent Condition" shall mean that valid consents to the proposed amendments to the Existing Subordinated Notes Indenture have been duly delivered and not revoked in respect of at least a majority of the outstanding principal amount of Existing Subordinated Notes pursuant to the Tender Offer and Consent Solicitation. It is understood that after giving effect to the Transaction (as defined below), the "borrower" under the Facilities referred to below and the issuer of the Senior Subordinated Notes referred to below shall be the survivor of the Merger. The sources of funds needed to finance the Merger and the Refinancing, to pay all fees and expenses incurred in connection with the Transaction (as defined below) and to finance the Borrower's and its subsidiaries' working capital and general corporate requirements shall initially be provided solely through the following sources: (a) at least 35% of the pro forma capitalization of the Company after giving effect to the Transaction will be provided to Holdings through new cash common equity contributions (or preferred equity interests upon terms reasonably acceptable to the Lead Arranger) and the rollover of shares of common equity of the Company into Holdings' or the Borrower's common equity by management shareholders (not to exceed $10.0 million) (together, the "Equity Financing"); (b) $375.0 million in senior secured credit facilities of the Borrower, comprised of (i) term loan facilities aggregating $325.0 million (the "Term Loan Facility") and (ii) a revolving credit facility of $50.0 million (the "Revolving Credit Facility" and, together with the Term Loan Facility, the "Senior Secured Financing"); and (c) $215.0 million in gross proceeds from the issuance and sale by the Borrower of senior subordinated notes (the "Senior Subordinated Notes") or, alternatively, $215.0 million of senior subordinated loans under a bridge facility (the "Bridge Facility" and, together with the Senior Secured Financing, the "Facilities") made available to the Borrower as interim financing to the Permanent Securities referred to below (such senior subordinated loans being the "Bridge Loans" and, together with any Rollover Loans and Exchange Notes (each as defined in Annex II hereto), the "Bridge Financing"); it being understood that (x) up to $325.0 million of the Term Loan Facility shall be drawn on the closing date of the Merger (the closing date of the Merger and the date on which the initial drawing is made under the Term Loan Facility, the "Closing Date") to effect the Merger and the Refinancing and to pay fees and expenses incurred in connection therewith; and (y) no more than $20.0 million of the Revolving Credit Facility (other than with respect to existing letters of credit which are "rolled-in" to, or "back-stopped" with letters of credit issued under, the Senior Secured Financing) may be utilized on the Closing Date to make payments owing to effect the Merger, the Refinancing, and to pay any fees and expenses incurred in connection therewith (although after the Closing Date and until the maturity of the Revolving Credit Facility, loans may be borrowed, repaid and reborrowed thereunder from time to time for the purposes described in the summary of certain of the terms and conditions of the Senior Secured Financing attached hereto as Annex I and Annex III (the "Senior Term Sheet"). 2 To the extent that less than all of the Existing Subordinated Notes are accepted for purchase in the Tender Offer and Consent Solicitation, the amount of the Term Loan Facility, the Bridge Facility (to the extent any amount of the Bridge Loans would otherwise be funded on the Closing Date) and/or the Senior Subordinated Notes shall be reduced on a dollar for dollar basis in a manner and pursuant to an allocation, mutually agreed by you and the Joint Lead Arrangers (as defined below), provided, that the commitments in respect of such amounts so reduced shall be available for up to 90 days following the Closing Date to fund any required change of control offer under the Existing Subordinated Notes Indenture for any Existing Subordinated Notes that are not tendered in the Tender Offer and Consent Solicitation. The Merger, the Equity Financing, the entering into and funding of the Senior Secured Financing, the issuance and sale of the Senior Subordinated Notes or the entering into and funding of the Bridge Facility, the Refinancing and all related transactions are hereinafter collectively referred to as the "Transaction." Banc of America Securities LLC ("BAS") and Credit Suisse Securities (USA) LLC ("CS Securities") have also delivered to you a separate engagement letter dated the date hereof (the "Engagement Letter") setting forth the terms on which BAS and CS Securities are willing to act as joint lead underwriters, initial purchasers, arrangers and placement agents for (i) the Senior Subordinated Notes or (ii) if the Bridge Facility is funded on the Closing Date, the senior subordinated notes or any other debt securities of the Borrower or of Holdings that may be issued after the Closing Date for the purpose of refinancing all or a portion of the outstanding amounts under the Bridge Facility (the "Permanent Securities"). Please note that those matters (other than with respect to the conditions precedent to the Facilities which are set forth herein and in the Term Sheets which conditions are set forth herein and therein in full) that are not covered or made clear herein, in the Term Sheets (as defined below), in the Fee Letter (as defined below) or in the Engagement Letter are subject to mutual agreement of the parties. 1. Commitments. In connection with the foregoing, (a) Bank of America, N.A. ("BofA") is pleased to confirm that it commits to provide 66.67% of the Senior Secured Financing and Credit Suisse ("CS") is pleased to confirm that it commits to provide 33.33% of the Senior Secured Financing, subject to the terms and conditions set forth herein and in the Senior Term Sheet, (b) BofA is pleased to confirm that it will act as sole administrative agent (in such capacity, the "Senior Administrative Agent") and CS is pleased to confirm that it will act as sole syndication agent (in such capacity, the "Senior Syndication Agent") for the Senior Secured Financing, (c) BAS and CS Securities are pleased to confirm that they commit to act as joint lead arrangers and joint lead book runners (in such capacity, the "Senior Joint Lead Arrangers") for the Senior Secured Financing, (d) Banc of America Bridge LLC ("Banc of America Bridge" and together with CS Securities, the "Bridge Commitment Parties" and, together with the Senior Commitment Parties, the "Commitment Parties"), is pleased to confirm that it commits to provide 66.67% of the Bridge Facility and CS is pleased to confirm that it commits to provide 33.33% of the Bridge Facility, subject to the terms and conditions set forth herein and in the summary of terms attached as Annex II and Annex III hereto (collectively, the "Bridge Term Sheet" and, together with the Senior Term Sheet, the "Term Sheets"), (e) Banc of America Bridge is pleased to confirm that it will act as sole administrative agent (in such capacity, the "Bridge Administrative 3 Agent") and CS is pleased to confirm that it will act as sole syndication agent (in such capacity, the "Bridge Syndication Agent") for the Bridge Facility and (f) BAS and CS Securities are pleased to confirm that they commit to act as lead arrangers and lead book runners (in such capacity, the "Bridge Joint Lead Arrangers"; BAS and CS Securities, acting in their capacity as Senior Joint Lead Arrangers and/or Bridge Joint Lead Arrangers, are sometimes referred to herein as the "Joint Lead Arrangers") for the Bridge Facility (with BAS on the "left"). 2. Syndication. The Joint Lead Arrangers intend to commence syndication of each of the Facilities to one or more financial institutions reasonably acceptable to you (collectively with the Commitment Parties, the "Lenders") that will become party to definitive credit documentation pursuant to a syndication to be managed by the Joint Lead Arrangers in consultation with you promptly after your acceptance of the terms of this Commitment Letter (as defined below) and the Fee Letter (as defined below); provided that, notwithstanding the Joint Lead Arrangers' right to syndicate the Facilities and receive commitments with respect thereto, the Joint Lead Arrangers and the Commitment Parties shall not assign all or any portion of their commitments hereunder prior to the Closing Date. You further agree to actively assist the Joint Lead Arrangers in achieving a syndication of each such Facility that is reasonably satisfactory to the Joint Lead Arrangers and you. Such assistance shall include (a) your providing, and causing your advisors and using commercially reasonable efforts to ensure that the Company and its advisors provide, the Joint Lead Arrangers and the Lenders upon request with all available information reasonably deemed necessary by the Joint Lead Arrangers to complete such syndication, including, but not limited to, information and evaluations prepared by you, the Company and your or its advisors, or on your or its behalf, relating to the Transaction, (b) your assisting, and using commercially reasonable efforts to ensure that the Company assists, in the preparation of an Information Memorandum to be used in connection with the syndication of each such Facility (collectively, the "Information Memoranda"), (c) your using commercially reasonable efforts to ensure that the syndication efforts of the Joint Lead Arrangers benefit materially from your existing lending relationships and the existing lending relationships of the Sponsor and the Company, (d) your otherwise assisting, and using commercially reasonable efforts to ensure that the Sponsor and the Company assists the Joint Lead Arrangers in their syndication efforts with respect to the Facilities and their efforts in marketing the Senior Subordinated Notes, including by making, upon reasonable notice, certain of your officers and advisors and using commercially reasonable efforts to make certain of the officers and advisors of the Company available from time to time to attend and make presentations regarding the business and prospects of the Company and its subsidiaries, as appropriate, at one or more meetings of prospective Lenders, and (e) your using commercially reasonable efforts to ensure that the applicable Facilities and the Senior Subordinated Notes (if applicable) shall have received a debt rating from Moody's Investor Services, Inc. ("Moody's") and from Standard & Poor's Ratings Group ("S&P") as promptly as practicable following the date hereof. You hereby agree that prior to the Closing Date you shall have completed and made available to the Joint Lead Arrangers and potential Lenders and investors (i) the Information Memoranda (including a separate offering memorandum for both public and private investors) to be used in connection with the syndication of the Facilities and (ii) the completed Preliminary Offering Memorandum for the offering and sale of the Senior Subordinated Notes pursuant to Rule 144A and Regulation S of the rules and regulations of the Securities Act, in each case containing such disclosures as may be required by applicable laws 4 and as are customary and appropriate for such a document in such an offering by an affiliate of the Sponsor and as may be reasonably required by the Joint Lead Arrangers (the "Offering Memorandum"). Without limiting the provisions of the immediately preceding sentence, it is understood and agreed such Offering Memorandum referred to in clause (ii) of such sentence shall (x) be suitable for use in a customary "high-yield road show" relating to the Senior Subordinated Notes and (y) except as otherwise agreed to by the Joint Lead Arrangers, contain all financial statements (including all audited financial statements, all unaudited financial statements (which, in the case of the Company's unaudited financial statements, shall have been reviewed by the independent certified accountants for the Company as provided in Statement on Auditing Standards No. 100) and all appropriate pro forma financial statements prepared in accordance with, or reconciled to, generally accepted accounting principles in the United States and prepared in accordance with Regulation S-X under the Securities Act subject to exceptions customary in offering memoranda used in Rule 144A offerings by affiliates of the Sponsor and all other financial data that would be necessary for the Joint Lead Arrangers to receive customary "comfort" (including "negative assurance" comfort) from independent certified accountants in connection with the offering of the Senior Subordinated Notes. You agree that unless otherwise agreed to by the Joint Lead Arrangers during the period from the execution of this Commitment Letter until the completion of the syndication of each Facility (as reasonably determined by the Joint Lead Arrangers) you will not and you will cause your subsidiaries not to (and will use your commercially reasonable best efforts to cause the Company and its subsidiaries not to), syndicate or issue, attempt to syndicate or issue, announce or authorize the announcement of the syndication or issuance of, any competing debt security or commercial bank or debt facility (including refinancings and renewals thereof but excluding borrowings of revolving loans under the Company's existing revolving credit facilities) other than the Facilities and the Senior Subordinated Notes. It is understood and agreed that the Joint Lead Arrangers will manage and control all aspects of the syndication of each Facility in consultation with you, including decisions as to the selection of prospective Lenders (all of whom, as set forth above, shall be reasonably acceptable to you) and any titles offered to proposed Lenders, when commitments will be accepted and the final allocations of the commitments among the Lenders. It is understood that no Lender participating in any Facility will receive compensation from you in order to obtain its commitment, except on the terms contained herein, in the Term Sheets, the Fee Letter and the Engagement Letter. It is also understood and agreed that the allocation and distribution of the fees among the Lenders will be determined by the Joint Lead Arrangers in consultation with you. Without limiting your obligations to assist with syndication efforts as set forth above, the Joint Lead Arrangers and the Commitment Parties agree that completion of such syndications shall not be a condition to the Commitment Parties' commitments hereunder. 3. Conditions to Financing. The Commitment Parties' commitments and agreements hereunder are subject to the satisfaction of the conditions set forth herein and in Annex III attached hereto, and each of the following conditions: (a) in the case of the Senior Secured Financing, you shall have accepted the Fee Letter with respect to the Senior Secured Financing as provided therein, (b) in the case of the Bridge Facility, you shall have accepted (x) the Fee Letter with respect to the Bridge Facility as provided therein and (y) the Engagement Letter, and, thereafter, the 5 Engagement Letter shall remain in full force and effect, and (c) since December 31, 2005, except as set forth in Section 3.7 of the Company Disclosure Schedule (as defined in the Merger Agreement) or except as set forth in the Filed Company SEC Reports (as defined in the Merger Agreement) there has not been any change, event, circumstance, condition, occurrence, development or effect that, individually or in the aggregate, has had, or would reasonably be expected to have, a Company Material Adverse Effect. For purposes hereof, the term "Company Material Adverse Effect" means changes, events, circumstances, conditions, occurrences, developments or effects that, individually or in the aggregate, has or would reasonably be expected to have a material adverse effect on the business, properties, assets, liabilities, condition (financial or otherwise) or results of operations of the Company and its subsidiaries, taken as a whole, or that would reasonably be expected to prevent the Company from consummating the transactions contemplated by the Merger Agreement; provided, however, that none of the following, either individually or in the aggregate, shall be deemed to constitute, or be taken into account in determining whether there has been or will be, a Company Material Adverse Effect: (i) a change in the trading price of any of the Company's securities, in and of itself; (ii) reductions in regulatory reimbursement rates affecting the Company taking effect after the execution of the Merger Agreement and the effects, changes, events, circumstances and conditions resulting therefrom; (iii) changes in GAAP or applicable laws after the execution of the Merger Agreement; (iv) changes, events, circumstances, conditions, occurrences, developments or effects resulting from the announcement of the execution of the Merger Agreement or of the pendency of the Merger; (v) changes, events, circumstances, conditions, occurrences, developments or effects resulting from compliance by the Company with the terms of, or the taking of any action specifically required to be taken in, the Merger Agreement (other than the consummation of the Merger itself); (vi) changes, events, circumstances, conditions, occurrences, developments or effects or conditions affecting the business in which the Company and its subsidiaries operate generally; (vii) changes in economic, financial or political conditions generally; (viii) any act of terrorism or war (whether or not declared); (ix) any failure by the Company and its subsidiaries, in and of itself, to meet projections, budgets or forecasts or published revenue or earnings predictions; and (x) any reclassifications, restructuring charges, non-recurring charges, increases in reserves and writeoffs of, to or in the financial statements of the Company and/or Compex described in (and up to the amount set forth in) Section 7.2(d)(ii) of the Merger Agreement, except, in the case of clauses (ii), (vi), (vii) and (viii) above, to the extent such changes, events, circumstances, conditions, occurrences, developments or effects have a materially disproportionate adverse effect on the Company and its subsidiaries as compared to other persons engaged in the same business. Notwithstanding anything in this Commitment Letter, the Term Sheets, the Fee Letter, the definitive documentation for the Facilities (the "Facilities Documentation") or any other letter agreement or other undertaking concerning the financing of the Transaction to the contrary, (i) the only representations relating to the Company, its subsidiaries and their businesses the making of which shall be a condition to availability of the Facilities on the Closing Date shall be (A) such of the representations made by the Company in the Merger Agreement as are material to the interests of the Lenders, but only to the extent that you have the right to terminate your obligations under the Merger Agreement as a result of a breach of such representations in the Merger Agreement and (B) the Specified Representations (as defined below) and (ii) the terms of the Facilities Documentation shall be in a form such that they do not impair availability of the Facilities on the Closing Date if the conditions set forth herein and in the Term Sheets are satisfied (it being understood that, to the 6 extent any guarantee or collateral is not provided on the Closing Date after your use of commercially reasonable efforts to do so, the delivery of such guarantee and/or collateral shall not constitute a condition precedent to the availability of the Facilities on the Closing Date but shall be required to be delivered after the Closing Date pursuant to arrangements to be mutually agreed). For purposes hereof, "Specified Representations" means the representations and warranties of the Borrower set forth in the Term Sheets relating to corporate power and authority, the enforceability of the Facilities Documentation, Federal Reserve margin regulations, the Investment Company Act and status of the Senior Secured Facilities as senior debt. 4. Information Requirements. You hereby represent, warrant and covenant that (a) to the best of your knowledge, all written information (other than the Projections (as defined below) and information of a general economic nature) (taken as a whole) which has been or is hereafter made available to us or the other Lenders by you, the Company or any of your or its representatives in connection with the Transaction or the other transactions contemplated herein (the "Information") is and will be correct in all material respects and does not and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the Information (taken as a whole) not misleading in light of the circumstances under which they were made, and (b) all financial projections that have been or are hereafter made available to us or the other Lenders by you, the Company or any of your or its representatives in connection with the Transaction and the other transactions contemplated hereby (the "Projections") have been or will be prepared in good faith based upon assumptions you believed to be reasonable at the time so made available. You agree to furnish us with such Information and Projections as we may reasonably request and to supplement the Information and the Projections from time to time until the Closing Date so that the representation, warranty and covenant in the preceding sentence is correct on the Closing Date. You understand that in arranging and syndicating the Facilities, the Joint Lead Arrangers will be using and relying on the Information and the Projections without independent verification thereof. The Information and Projections provided to the Joint Lead Arrangers prior to the date hereof are hereinafter referred to as the "Pre-Commitment Information." You hereby acknowledge that, in connection with the syndication of the Facilities, (a) the Joint Lead Arrangers will make available Information and Projections (collectively, "Borrower Materials") to the proposed syndicates of Lenders by posting the Borrower Materials on IntraLinks or another similar electronic system (the "Platform") and (b) certain of the proposed Lenders may be "public-side" Lenders (i.e., Lenders that do not wish to receive material non-public information with respect to the Borrower or its securities) (each, a "Public Lender"). You hereby agree that prior to the Closing Date (w) that portion of the Borrower Materials that may be distributed to Public Lenders shall be clearly and conspicuously marked "PUBLIC," which, at a minimum, shall mean that the word "PUBLIC" shall appear prominently on the first page thereof; (x) by marking Borrower Materials "PUBLIC," it is understood between the parties hereto that such Borrower Materials do not contain any material non-public information with respect to the Borrower or its securities, it being understood that certain of such Borrower Materials may be subject to the confidentiality requirements of the definitive credit documentation; (y) all Borrower Materials marked "PUBLIC" are permitted to 7 be made available through a portion of the Platform designated "Public Investor"; and (z) the Commitment Parties shall be entitled to treat any Borrower Materials that are not marked "PUBLIC" as being suitable only for posting on a portion of the Platform not designated "Public Investor." Notwithstanding the foregoing and except as set forth in the next sentence, you shall be under no obligation to mark any Borrower Materials "PUBLIC." However, you will include as part of such Borrower Materials and mark "PUBLIC" a reasonably detailed term sheet for the Facilities for distribution to the Public Lenders. 5. Fees and Indemnities. By accepting this letter, you hereby agree that, if the Closing Date occurs, (i) all our (and our affiliates') reasonable out-of-pocket expenses and the reasonable legal fees and expenses of counsel, consisting, in the case of legal fees and expenses of counsel, of fees and expenses of Shearman & Sterling LLP and such other relevant local counsel as may be retained with your consent in connection with security matters, arising in connection with this letter and the enforcement hereof (and the due diligence, marketing and syndication efforts of the Lead Arranger in connection herewith) and in connection with the Transaction shall be for your account, provided that the Joint Lead Arrangers shall not retain any consultants without your approval (which approval shall not be unreasonably withheld) and (ii) if this Commitment Letter is accepted with respect to the Bridge Facility, reasonable out-of-pocket fees and expenses incurred by the Bridge Joint Lead Arrangers in connection with the Senior Subordinated Notes or the Permanent Securities will be reimbursed on the terms provided in the Engagement Letter. You further agree to indemnify and hold harmless each Commitment Party, each Joint Lead Arranger and each director, officer, employee, agent and affiliate thereof (each an "indemnified person") from and against any and all actions, suits, proceedings (including any investigations or inquiries), claims, losses, damages, liabilities or expenses of any kind or nature whatsoever which may be incurred by or asserted against or involve any indemnified person as a result of or arising out of or in any way related to or resulting from this letter, the Transaction and any other transactions contemplated hereby and, upon demand, to pay and reimburse each indemnified person for any reasonable legal or other reasonable out-of-pocket expenses incurred in connection with investigating, defending or preparing to defend any such action, suit, proceeding (including any inquiry or investigation) or claim (whether or not any indemnified person is a party to any action or proceeding out of which any such expenses arise); provided, however, that you shall not have to indemnify any indemnified person against any loss, claim, damage, expense or liability to the extent the same resulted from the gross negligence, willful misconduct, or bad faith of, or breach of this Commitment Letter or the Facilities Documentation by, such indemnified person or its related parties (as determined by a court of competent jurisdiction). This Commitment Letter is issued for your benefit only and no other person or entity may rely hereon. None of the Joint Lead Arrangers, the Commitment Parties nor any other indemnified person shall be responsible or liable to you or any other person or entity for (x) any consequential damages which may be alleged as a result of this Commitment Letter or the financing contemplated hereby or (y) the use by others of information or other materials obtained through the Internet, Intralinks or other similar information transmission systems unless such liability arises from the gross negligence, willful misconduct, or bad faith of, or breach of this Commitment Letter or the Facilities Documentation by, such person (as determined by a court of competent jurisdiction). BAS and/or its affiliates have been retained as the sell-side financial advisor (in such capacity, the "Financial Advisor") to the Sellers in connection with the 8 Transaction. You agree to any such retention, and further agree not to assert any claim you might allege based on any actual or potential conflicts of interest that might be asserted to arise or result from, on the one hand, the engagement of the Financial Advisor or from BAS's and/or its affiliates' arranging or providing or contemplating arranging or providing financing for a competing bidder for the Company and, on the other hand, BofA's, Banc of America Bridge's and BAS's relationship with you as described and referred to herein. 6. Confidentiality. The Commitment Parties reserve the right to employ the services of their respective affiliates in providing services contemplated by this Commitment Letter and to allocate, in whole or in part, to such affiliates certain fees payable to the Commitment Parties in such manner as the Commitment Parties and such affiliates may agree in their sole discretion. You acknowledge the Commitment Parties may share with any of their respective affiliates, and such affiliates may share with the Commitment Parties (in each case on a need-to-know and confidential basis), any information related to the Transaction, the Sponsor (as such information relates to the Transaction), the Company and any of their respective subsidiaries, or any of the matters contemplated hereby. Consistent with each Commitment Party's policy to hold in confidence the affairs of its clients, such Commitment Party will not, and such Commitment Party will ensure that its affiliates will not, furnish confidential information obtained from you or your affiliates to any of its other clients. In particular, you acknowledge that you have been advised of the role of BAS and/or its affiliates as Financial Advisor and that, in such capacity, (i) the Financial Advisor may recommend to the Sellers that the Sellers not pursue or accept your offer or proposal for the Merger, (ii) the Financial Advisor may advise the Sellers in other manners adverse to your interests, including, without limitation, by providing advice on pricing, leverage levels and timing and conditions of closing with respect to your bid, taking other actions with respect to your bid and taking action under any definitive agreement between you and the Sellers, and (iii) the Financial Advisor may possess information about the Sellers and the Company, the Merger and other potential purchasers and their respective strategies and proposals, but the Financial Advisor shall have no obligation to disclose to you the substance of such information or the fact that it is in possession thereof. In addition, you acknowledge that BAS, Bank of America, Banc of America Bridge and their respective affiliates (collectively, the "BAS Entities") may be arranging or providing (or contemplating arranging or providing) a committed form of acquisition financing to other potential purchasers of the Company and that, in such capacity, such BAS Entities may acquire information about the Company, the sale thereof and such other potential purchasers and their strategies and proposals, but such BAS Entities shall have no obligation to disclose to you the substance of such information or the fact that such BAS Entities are in possession thereof. You hereby acknowledge and agree that the Commitment Parties and their affiliates may, from time to time, acquire or maintain ownership interests in, accept deposits from, lend money to, and generally engage in any kind of business (including, without limitation, banking, investment banking and financial advisory services) with other persons whose interests may conflict with yours without, by reason of such activities, incurring any liability to you. You further acknowledge that the Commitment Parties have no obligation to disclose to you or use for your benefit any confidential information obtained from the Sellers, the Company or any 9 other persons. The Commitment Parties will not, and will ensure that their affiliates will not, disclose to the Sellers, the Company or any other persons any confidential information. You agree that this Commitment Letter is for your confidential use only and that neither its existence nor the terms or a copy hereof will be disclosed by you to any person or entity other than the Sponsor and its and your shareholders, officers, directors, employees, accountants, attorneys and other advisors (your "Representatives"), and then only on a "need to know" basis in connection with the transactions contemplated hereby and on a confidential basis; provided that you may disclose this Commitment Letter (and the nature of the provisions related to "market flex" in the Fee Letter) to the Sellers and their officers, directors, employees, accountants, attorneys and other advisors on a confidential basis in connection with their consideration of the Transaction. Notwithstanding the foregoing, following your acceptance of the provisions hereof and your return of an executed counterpart of this Commitment Letter, the related Fee Letter dated the date hereof between you and us (the "Fee Letter"), and the Engagement Letter to us as (and if) provided below, (i) you may make public disclosure of the existence and amount of the commitments hereunder and of our identity, (ii) you may file a copy of this Commitment Letter (but not the Fee Letter or the Engagement Letter) in any public record in which it is required by law to be filed and (iii) you may make such other public disclosure of the terms and conditions hereof as, and to the extent, you are required by law or regulation to make; provided, that foregoing restrictions shall cease to apply (except in respect of the Fee Letter and the Engagement Letter) after the Facilities Documentation shall have been executed and delivered by the parties thereto. In connection with all aspects of each transaction contemplated by this letter, you acknowledge and agree that: (i) the Facilities and any related arranging or other services described in this letter are arm's-length commercial transactions between you and your affiliates, on the one hand, and the Commitment Parties, on the other hand, and you are capable of evaluating and understanding, and understand and accept the terms, risks and conditions of the transactions contemplated by this Commitment Letter; (ii) in connection with the process leading to such transactions, each Commitment Party is and has been acting solely as a principal and is not the financial advisor, agent or fiduciary, for you or any of your affiliates, stockholders, creditors or employees or any other party; (iii) none of the Commitment Parties has assumed or will assume an advisory, agency or fiduciary responsibility in your or your affiliates' favor with respect to any of the transactions contemplated hereby or the process leading thereto (irrespective of whether any of the Commitment Parties has advised or is currently advising you or your affiliates on other matters) and none of the Commitment Parties has any obligation to you or your affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth in this Commitment Letter, the Fee Letter and, if you accept this Commitment Letter as to the Bridge Facility, the Engagement Letter; (iv) the Commitment Parties and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from yours and your affiliates and the Commitment Parties have no obligation to disclose any of such interests by virtue of any advisory, agency or fiduciary relationship; and (v) the Commitment Parties have not provided any legal, accounting, regulatory or tax advice with respect to any of the transactions contemplated hereby and you have consulted your own legal, accounting, regulatory and tax advisors to the extent you have deemed appropriate. You hereby waive and release, to the fullest extent permitted by law, any claims 10 that you may have against the Commitment Parties with respect to any breach or alleged breach of agency or fiduciary duty. 7. Survival. Except as specifically set forth herein or in the Fee Letter, the provisions of Sections 5 and 6 shall survive any termination of this Commitment Letter. 8. Patriot Act Requirements. The Lead Arranger and the Commitment Parties hereby notify you that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the "Act"), each of them is required to obtain, verify and record information that identifies you, which information includes your name and address and other information that will allow the Commitment Parties, as applicable, to identify you and the Borrower in accordance with the Act. 9. Miscellaneous. This letter and the Term Sheets (collectively, the "Commitment Letter") are furnished for your benefit only, may not be relied upon by any other person or entity and is not assignable by you to any person or entity (other than the Mergeco)without our prior written consent (and any purported assignment without such consent shall be null and void). This Commitment Letter, the Fee Letter and the Engagement Letter may not be amended or waived except by an instrument in writing signed by each of the parties hereto and thereto, as the case may be. Each of this Commitment Letter, the Fee Letter and the Engagement Letter may be executed in any number of counterparts, each of which shall be an original and all of which, when taken together, shall constitute one agreement. Delivery of an executed signature page of this Commitment Letter, the Fee Letter or the Engagement Letter by facsimile or other electronic transmission shall be effective as delivery of a manually executed counterpart hereof or thereof, as the case may be. This Commitment Letter and the Fee Letter (and, if this Commitment Letter is accepted with respect to the Bridge Facility, the Engagement Letter) set forth the entire agreement between the parties hereto as to the matters set forth herein and supersede all prior communications, written or oral, with respect to the matters herein. Each Commitment Party's willingness, and commitments, with respect to the Facilities as set forth above will terminate on January 31, 2007 unless on or prior to such date (i) the Merger has been consummated, (ii) a definitive credit agreement evidencing the Senior Secured Financing, consistent with the terms and conditions set forth herein, shall have been entered into and the initial borrowings shall have occurred thereunder and (iii) either the Senior Subordinated Notes have been issued or, alternatively, the Bridge Loans have been incurred (or a combination thereof), in each such case pursuant to documentation consistent with the terms and conditions set forth herein. If you are in agreement with the foregoing (i) with respect to the Senior Secured Financing, please sign and return to us (including by way of facsimile or other electronic transmission) the enclosed copy of this Commitment Letter, together with the related Fee Letter to accept the commitments and undertakings under the Senior Secured Financing, no later than 11 5:00 p.m., New York time, on July 7, 2006 and (ii) with respect to the Bridge Facility, please sign and return to us (including by way of facsimile transmission) the enclosed copy of this Commitment Letter, together with the related Fee Letter and the Engagement Letter to accept the commitments and undertakings under the Bridge Facility, no later than 5:00 p.m., New York time, on July 7, 2006. The commitments and undertakings of the Senior Commitment Parties under this Commitment Letter with respect to the Senior Secured Financing shall terminate at the time and on the date referenced in the immediately preceding sentence unless this Commitment Letter and the related Fee Letter are executed and returned by you as provided in clause (i) of such sentence. The commitments and undertakings of the Bridge Commitment Parties under this Commitment Letter with respect to the Bridge Facility shall terminate at the time and on the date referenced in the second preceding sentence unless this Commitment Letter, the related Fee Letter and the Engagement Letter are executed and returned by you as provided in clause (ii) of such sentence. BY SIGNING THIS COMMITMENT LETTER, EACH OF THE PARTIES HERETO HEREBY ACKNOWLEDGES AND AGREES THAT (A) EACH OF BOFA AND CS IS OFFERING TO PROVIDE THE SENIOR SECURED FINANCING SEPARATE AND APART FROM BANC OF AMERICA BRIDGE'S AND CS' OFFER TO PROVIDE THE BRIDGE FACILITY AND (B) EACH OF BANC OF AMERICA BRIDGE AND CS IS OFFERING TO PROVIDE THE BRIDGE FACILITY SEPARATE AND APART FROM THE OFFER BY BOFA AND CS TO PROVIDE THE SENIOR SECURED FINANCING. YOU MAY, AT YOUR OPTION, ELECT TO ACCEPT THIS COMMITMENT LETTER (AND THE APPLICABLE PROVISIONS OF THE FEE LETTER) WITH RESPECT TO EITHER THE SENIOR SECURED FINANCING OR THE BRIDGE FACILITY OR BOTH. THIS COMMITMENT LETTER AND THE FEE LETTER SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK, AND ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM, ACTION, SUIT OR PROCEEDING ARISING OUT OF OR CONTEMPLATED BY THIS COMMITMENT LETTER AND/OR THE FEE LETTER IS HEREBY WAIVED BY EACH PARTY HERETO. YOU HEREBY SUBMIT TO THE NON-EXCLUSIVE JURISDICTION OF THE FEDERAL AND NEW YORK STATE COURTS LOCATED IN THE COUNTY OF NEW YORK IN CONNECTION WITH ANY DISPUTE RELATED TO THIS COMMITMENT LETTER AND/OR THE FEE LETTER OR ANY MATTERS CONTEMPLATED HEREBY OR THEREBY. 12 EXECUTION VERSION Very truly yours, BANC OF AMERICA SECURITIES LLC By /s/ Mark C. Liggitt -------------------------- Name: Mark C. Liggitt Title: Vice President BANK OF AMERICA, N.A. By /s/ Douglas M. Ingram -------------------------- Name: Douglas M. Ingram Title: Managing Director BANC OF AMERICA BRIDGE LLC By /s/ Mark C. Liggitt -------------------------- Name: Mark C. Liggitt Title: Vice President CREDIT SUISSE SECURITIES (USA) LLC By /s/ Alexis F. Maged ------------------------- Name: Alexis F. Maged Title: Managing Director CREDIT SUISSE, CAYMAN ISLANDS BRANCH By /s/ Doreen Barr ------------------------- Name: Doreen Barr Title: Vice President By /s/ Adam Forchheimer ------------------------- Name: Adam Forchheimer Title: Vice President Commitment Letter EXECUTION VERSION The provisions of this Commitment Letter with respect to the Senior Secured Financing are accepted and agreed to as of the date first written above: GRAND SLAM HOLDINGS, LLC By: /s/ Chinh E. Chu ---------------------------- Name: Chinh E. Chu Title: President The provisions of this Commitment Letter with respect to the Bridge Facility are accepted and agreed to as of the date first written above: GRAND SLAM HOLDINGS, LLC By: /s/ Chinh E. Chu ---------------------------- Name: Chinh E. Chu Title: President Commitment Letter ANNEX I-A SUMMARY OF CERTAIN TERMS OF SENIOR CREDIT FACILITIES Unless otherwise defined herein, capitalized terms used herein and defined in the letter agreement to which this Annex I is attached (the "Commitment Letter") are used herein as therein defined. I. Description of Credit Facilities Holdings: Grand Slam Holdings, LLC ("Holdings") which shall own substantially all of the outstanding equity interests of the Borrower (as defined below). Borrower: A newly formed subsidiary of Holdings which shall own (either directly or indirectly) all of the assets owned by the Company immediately prior to the consummation of the Merger (the "Borrower"). Credit Facilities: 1. Term loan facility in an aggregate principal amount of $325.0 million (the "Term Loan Facility"). 2. Revolving credit facility in an aggregate principal amount of $50.0 million (the "Revolving Credit Facility"). A. Term Loan Facility Use of Proceeds: The loans made pursuant to the Term Loan Facility (the "Term Loans") may be incurred (A) on the Closing Date, in an amount up to $325.0 million, solely (i) to finance the Merger, (ii) to consummate the Refinancing, (iii) to pay the fees and expenses incurred in connection with the Transaction and (iv) for working capital, capital expenditures and other general corporate purposes. Maturity: The final maturity date of the Term Loan Facility shall be 7 years from the Closing Date (the "Term Loan Maturity Date"). Amortizations: (i) During the first 6 years and 9 months following the Closing Date, annual amortization (payable in equal quarterly installments) of the Term Loans shall be required in an amount equal to one percent of the initial aggregate amount of the Term Loans. (ii) The remaining aggregate principal amount of Term Loans shall be payable on the Term Loan Maturity Date. Commitment Letter B. Revolving Credit Facility Use of Proceeds: The loans made pursuant to the Revolving Credit Facility (the "Revolving Loans") may be utilized solely for the working capital, capital expenditures and other general corporate purposes (including permitted acquisitions) of the Borrower and its subsidiaries; provided that up to $20.0 million of the Revolving Credit Facility may be utilized to effect the Transaction and to pay the fees and expenses incurred in connection therewith. Up to an amount to be agreed of the Revolving Credit Facility will be available for the issuance of letters of credit ("Letters of Credit"). In addition, up to an amount to be agreed of the Revolving Credit Facility will be available for the incurrence of swingline loans. Maturity: The final maturity of the Revolving Credit Facility shall be 6 years from the Closing Date (the "Revolving Credit Maturity Date"). Maturities for Letters of Credit will not exceed twelve months, renewable annually thereafter, but in no event shall such maturities extend beyond, the third business day prior to the Revolving Credit Maturity Date. Availability: Revolving Loans may be borrowed, repaid and reborrowed on and after the Closing Date and prior to the Revolving Credit Maturity Date. II. Terms Applicable to All Facilities Senior Administrative Agent: Bank of America, N.A. ("BofA") (in such capacity, the "Senior Administrative Agent"). Senior Syndication Agent: Credit Suisse ("CS"). Senior Lead Arrangers and Book Runners: Banc of America Securities LLC and Credit Suisse Securities (USA) LLC (in suchcapacity, the "Senior Joint Lead Arrangers"). Senior Lenders: BofA, CS and/or a syndicate of other lenders formed by the Senior Joint Lead Arrangers (the "Senior Lenders") reasonably acceptable to the Borrower. Required Senior Lenders: Senior Lenders having aggregate commitments and/or outstandings (as appropriate) pertaining to all tranches (taken in the aggregate) in excess of 50%. Guaranties: Holdings and each existing and future direct and indirect wholly-owned domestic subsidiary of Holdings (other than certain immaterial subsidiaries to be agreed upon and only to the extent permitted by applicable law) other than the Borrower (each a "Guarantor" and, collectively, the "Guarantors") shall be required I-A-2 to provide an unconditional guaranty of all amounts owing under the Senior Credit Facilities and under hedging and cash management agreements (with Lenders and affiliates of Lenders) (the "Guaranties"). Security: All amounts owing under the Senior Credit Facilities and under hedging and cash management agreements (with Lenders and affiliates of Lenders) (including, in each case, all obligations under the Guaranties) will be secured subject to exceptions to be agreed upon) by (x) a first priority perfected security interest in substantially all capital stock and promissory notes (subject to a minimum threshold to be agreed) of the Borrower (limited to the amount owned by Holdings) and each of the direct and indirect subsidiaries of the Borrower now or hereafter owned by the Borrower and the Guarantors, provided that the pledge of the capital stock of non-U.S. subsidiaries of the Borrower shall be limited solely to the pledge of no more than 65% of the total outstanding capital stock of the Borrower's "first tier" non-U.S. subsidiaries, and (y) a first priority perfected security interest in all other tangible and intangible assets (including receivables, contracts, contract rights, securities, patents, trademarks, other intellectual property, inventory, equipment, and owned real estate but excluding deposit accounts, or other bank or securities accounts and leasehold mortgages) now or hereafter owned by the Borrower and each Guarantor, subject only to Permitted Liens (to be defined with such modifications as may be appropriate under the circumstances), customary exceptions for transactions of this type with affiliates of the Sponsor so long as and to the extent reasonably acceptable to the Senior Joint Lead Arrangers. All documentation (collectively referred to herein as the "Security Agreements") evidencing the security required pursuant to the immediately preceding paragraph shall be in form and substance reasonably satisfactory to the Senior Joint Lead Arrangers and the Borrower. Notwithstanding the foregoing, the Senior Administrative Agent may agree to exclude particular assets from the collateral where it reasonably determines that the cost of obtaining and perfecting a security interest, lien, or mortgage is excessive in relation to the benefit afforded to the Lenders thereby. Incremental Facilities: The Borrower shall be permitted to add one or more incremental term loan facilities to the Senior Secured Facilities (each, an "Incremental Term Facility") and/or increase commitments under the Revolving Facility (any such increase, an "Incremental Revolving Facility"; the Incremental Term Facilities and the Incremental Revolving Facilities are collectively referred to as "Incremental Facilities") in an aggregate I-A-3 amount of up to $150,000,000; provided that (i) no Lender will be required to participate in any such Incremental Facility, (ii) no event of default or default exists or would exist after giving effect thereto, (iii) all financial covenants would be satisfied on a pro forma basis on the date of incurrence and for the most recent determination period, after giving effect to such Incremental Facility and other customary and appropriate pro forma adjustment events, including any acquisitions or dispositions or repayment of indebtedness after the beginning of the relevant determination period but prior to or simultaneous with the borrowing under such Incremental Facility, (iv) the maturity date of any such Incremental Term Facility shall be no earlier than the maturity dates of the Term Loan Facility, (v) the interest rates and amortization schedule applicable to any Incremental Term Facility shall be determined by the Borrower and the lenders thereunder, and (vi) any Incremental Revolving Facility shall be on terms and pursuant to documentation applicable to the Revolving Facility and any Incremental Term Facility shall be on terms and pursuant to documentation to be determined; provided that, to the extent such terms and documentation are not consistent with the Term Loan Facility (except to the extent permitted by clause (iv) or (v) above), they shall be reasonably satisfactory to the Joint Lead Arrangers. It is understood and agreed that the Facilities Documentation shall not contain any "most favored nation" provisions. Voluntary Prepayments/ Commitment Reductions: Voluntary prepayments of the Senior Loans may be made at any time on three business days' notice in the case of Eurodollar Loans, or one business day's notice in the case of Base Rate Loans, without premium or penalty, provided that voluntary prepayments of Eurodollar Loans made on a date other than the last day of an interest period applicable thereto shall be subject to customary breakage costs. The unutilized portion of the Revolving Credit Facility may be reduced or terminated by the Borrower on one business day's notice without premium or penalty. Mandatory Repayments: Mandatory repayments of Term Loans shall be required from (a) 100% of the net cash proceeds above an annual amount to be agreed from non-ordinary course asset sales (treating sales of equity interests by Holdings and its subsidiaries as asset sales) by Holdings and its subsidiaries, subject to exceptions to be agreed upon, including a 100% reinvestment right if reinvested or committed to reinvest within 15 months of such sale or disposition so long as reinvestment is completed within 180 days thereafter, (b) 100% of the net cash proceeds from issuances of debt by Holdings and its subsidiaries (other than debt permitted to be incurred under the Senior Credit Facilities, including, if the Bridge Facility is funded, the Rollover Loans or Exchange Notes or Permanent Securities in an initial principal amount sufficient to I-A-4 refinance any outstanding Bridge Loans), and (c) commencing with fiscal year 2007, 50% (with step-downs to 25% and 0% at leverage ratios to be agreed) of annual Excess Cash Flow (to be defined in a manner consistent with the definition thereof contained in financings with affiliates of the Sponsor, such definition to provide for a deduction from Excess Cash Flow, without duplication among periods, of operating cash used to finance acquisitions or to be used to finance acquisitions for which a binding agreement exists); provided that any voluntary prepayments of Senior Loans (including Revolving Loans to the extent commitments thereunder are permanently reduced by the amount of such prepayments) other than prepayments funded with the proceeds of incurrences of indebtedness, shall be credited against Excess Cash Flow prepayment obligations on a dollar-for-dollar basis. Application: All prepayments (voluntary and mandatory) to be applied in direct order. Waivable Prepayments: Senior Lenders holding Term Loans shall have rights to waive their share of mandatory repayments (excluding scheduled amortization) as otherwise required above (in which case the amounts so waived shall be retained by the Borrower). Interest Rates: At the Borrower's option, Senior Loans may be maintained from time to time as (x) Base Rate Loans, which shall bear interest at the Base Rate in effect from time to time plus the Applicable Margin or (y) Eurodollar Loans, which shall bear interest at the Eurodollar Rate (adjusted for maximum reserves) plus the Applicable Margin. "Applicable Margin" (x) in the case of Eurodollar Loans, shall have the meaning set forth in Annex I-B attached to the Commitment Letter and (y) in the case of Base Rate Loans, shall mean the percentage per annum which is 1.00% lower than the Applicable Margin for Eurodollar Loans. "Base Rate" shall mean the higher of (x) the rate that the Senior Administrative Agent announces from time to time as its prime lending rate, as in effect from time to time, and (y) 1/2 of 1% in excess of the overnight federal funds rate. Interest periods of 1, 2, 3 and 6 months and, if available to all of the Senior Lenders of the respective tranche of loans, one week and 9 and 12 months, shall be available in the case of Eurodollar Loans. The Senior Credit Facilities shall include protective provisions for such matters as defaulting banks, capital adequacy, increased costs, reserves, funding losses, illegality and withholding taxes. The Borrower shall have the right to replace any Senior Lender that (i) charges a material I-A-5 amount in excess of that being charged by the other Senior Lenders with respect to contingencies described in the immediately preceding sentence or (ii) objects to certain amendments to the Senior Credit Facilities that require each Senior Lender's consent so long as the Required Senior Lenders have agreed to such amendments. Interest in respect of Base Rate Loans shall be payable quarterly in arrears on the last business day of each calendar quarter. Interest in respect of Eurodollar Loans shall be payable in arrears at the end of the applicable interest period and every three months in the case of interest periods in excess of three months. Interest will also be payable at the time of repayment of any Senior Loans and at maturity. All interest on Base Rate Loans, Eurodollar Loans and commitment fees and any other fees shall be based on a 360-day year (or a 365/366-day year in the case of Base Rate Loans based on the Senior Administrative Agent's prime lending rate) and actual days elapsed. Default Interest: Overdue amounts shall bear interest at a rate per annum equal to the rate which is 2% in excess of the rate then borne by such borrowings. Such interest shall be payable on demand. Commitment Fees: 1/2 of 1% per annum of the unutilized commitments of each Senior Lender under the Revolving Credit Facility (treating the loans (including, in the case of the swingline lender, any swingline loans) of each Senior Lender under the Revolving Credit Facility and its ratable share of any outstanding Letters of Credit and unpaid drawings relating thereto as utilizations of such Senior Lender's commitment under the Revolving Credit Facility), as in effect from time to time, commencing on the Closing Date to but excluding the termination of the Revolving Credit Facility, payable quarterly in arrears with steps-downs to be agreed. Letter of Credit Fees: A letter of credit fee equal to the Applicable Margin as in effect from time to time for Revolving Loans maintained as Eurodollar Loans on the outstanding stated amount of Letters of Credit (the "Letter of Credit Fee") to be shared proportionately by the Senior Lenders in accordance with their participation in the respective Letter of Credit, and a facing fee of ? of 1% per annum or such other amount as shall be agreed (the "Facing Fee") to be paid to the issuer of each Letter of Credit for its own account, in each case calculated on the aggregate stated amount of all Letters of Credit for the stated duration thereof. Letter of Credit Fees and Facing Fees shall be payable quarterly in arrears. In addition, the issuer of a Letter of Credit will be paid its customary administrative charges in connection with Letters of Credit issued by it. Assignments and Participations: Revolving Credit Facility Assignments: Each Lender will be permitted I-A-6 to make assignments in respect of the Revolving Credit Facility in a minimum amount equal to $5 million to other financial institutions approved by the Senior Administrative Agent and, so long as no payment or bankruptcy Event of Default has occurred and is continuing, the Borrower, which approval shall not be unreasonably withheld or delayed; provided, however, that the approval of the Borrower shall not be required in connection with assignments to other Lenders, to any affiliate of a Lender, or to any Approved Fund (as such term is defined in the definitive documentation) and the approval of the Senior Administrative Agent shall not be required in connection with assignments to other Lenders under the Revolving Credit Facility. Notwithstanding the foregoing, however, any Lender assigning a Commitment (as such term shall be defined in the definitive loan documentation) shall be required to obtain the approval of the Senior Administrative Agent, the Letter of Credit issuing bank, and the lender for any Swingline Loan, unless the proposed assignee is already a Lender. Term Loan Facility Assignments: Each Lender will be permitted to make assignments in respect of the Term Loan Facility in a minimum amount equal to $1 million to other financial institutions approved by the Senior Administrative Agent and, so long as no payment or bankruptcy Event of Default has occurred and is continuing, the Borrower which approvals shall not be unreasonably withheld or delayed; provided, however, that the approvals of the Senior Administrative Agent and the Borrower shall not be required in connection with assignments of the Term Loan Facility to other Lenders, to any affiliate of a Lender, or to any Approved Fund. Assignments Generally: Each Lender will also have the right, without consent of the Borrower or the Senior Administrative Agent, to assign as security all or part of its rights under the loan documentation to any Federal Reserve Bank. Participations: Lenders will be permitted to sell participations with voting rights limited to changes in amount, rate, maturity date and releases of all or substantially all of the Collateral or the value of the guarantees. Participants will have the same benefits as the Lenders (and will be limited to the amount of such benefits) with respect to yield protection and increased cost provisions, subject to customary limitations. Governing Law: All documentation shall be governed by New York law (except security documentation that the Senior Administrative Agent reasonably determines should be governed by local law). Conditions Precedent Under the Credit Documentation, the availability of the initial I-A-7 to the Closing Date: borrowing under the Senior Secured Facilities will be subject to the conditions precedent set forth in Annex III to the Commitment Letter and the terms of the Commitment Letter. The Credit Documentation shall not contain (a) any conditions precedent other than the conditions precedent set forth herein or in Annex III to the Commitment Letter or (b) any representation or warranty, affirmative or negative covenant or event of default not set forth in the Commitment Letter or the Annexes thereto, the accuracy, compliance or absence, respectively, of or with which would be a condition to the initial borrowing under the Senior Secured Facilities. Conditions to each Extension of Credit: (i) Except as specified in Section 3 of the Commitment Letter, all representations and warranties shall be true and correct in all material respects on and as of the date of each extension of credit (although any representations and warranties which expressly relate to a given date or period shall be required to be true and correct in all material respects as of the respective date or for the respective period, as the case may be), before and immediately after giving effect to such extension of credit and to the application of the proceeds therefrom, as though made on and as of such date. (ii) Except with respect to the initial drawings, no event of default, or event which with the giving of notice or lapse of time or both would be an event of default, shall have occurred and be continuing, or would result from such extension of credit. Representations and Warranties: The following, in each case, usual for facilities and transactions of this type for affiliates of the Sponsor, financial statements (including pro forma financial statements); absence of undisclosed liabilities; no material adverse change after the Closing Date; corporate existence; compliance with laws; corporate power and authority; binding effect and the enforceability of Credit Documents; no conflict with law or contractual obligations; no material litigation; no default; ownership of property; liens; intellectual property; taxes; Federal Reserve regulations; ERISA; Federal Reserve margin regulations; Investment Company Act; subsidiaries; environmental matters; solvency on the Closing Date; labor matters; accuracy of disclosure; creation and perfection of security interests; status of Senior Secured Facilities as senior debt; and such healthcare/medical industry Company specific representations and warranties to be agreed. Covenants: The following, in each case, usual for facilities and transactions of this type for affiliates of the Sponsor (including with respect to materiality thresholds): I-A-8 (i) Limitations on other indebtedness and preferred stock; provided that debt may be incurred or assumed in connection with a Permitted Acquisition (to be defined in the definitive documentation) subject only to pro forma compliance with the financial covenants. (ii) Limitations on mergers, acquisitions, partnerships and acquisitions and dispositions of assets; provided that the Borrower will be permitted to make acquisitions as long as (a) there is no default, (b) the Borrower would be in pro forma compliance with the financial covenants after giving effect thereto, (c) the acquired company or assets are in the same line of business as the Borrower and its subsidiaries and (d) the acquired company and its subsidiaries (other than immaterial subsidiaries) will become, in the case of any acquired entities organized under the laws of the U.S., Guarantors. Acquisitions of entities that do not become Guarantors will be limited to an aggregate amount to be agreed upon by the Lead Arranger and the Borrower. (iii) Limitations on sale-leaseback transactions. (iv) Limitations on dividends and other restricted payments. (v) Limitations on voluntary prepayments of subordinated indebtedness and amendments thereto. (vi) Limitations on transactions with affiliates. (vii) Limitations on investments. (viii) Maintenance of existence and properties. (ix) Maintenance of books and records. (x) Limitations on liens with exceptions to be agreed. (xi) Adequate insurance coverage. (xii) ERISA covenants. (xiii) Holding company activities. (xiv) Accounting changes. (xv) Change in line of business. (xvi) Burdensome agreements. I-A-9 (xvii) Financial reporting (limited to annual audited, quarterly unaudited and annual forecasts), certificates and other information, notice of material adverse change, environmental, ERISA-related matters, material litigation. (xviii) Visitation and inspection rights. (xix) Compliance with laws, including environmental, ERISA, FDA, HIPAA, and fraud and abuse laws. (xx) Payment of taxes and other liabilities. (xxi) Limitation on changes in nature of business. (xxii) Use of proceeds. (xxiii) Limitations on capital expenditures. (xxiv) Covenant to guarantee obligations and give security. (xxv) Further assurances. (xxvi) Financial covenants* (tested on a quarterly basis), measured for the Borrower and its consolidated subsidiaries on a consolidated basis and on a rolling four quarter basis in arrears beginning with the third financial quarter following the Closing Date, consisting of the following: (1) Minimum Interest Coverage Ratio (to be defined in a manner consistent with transactions with affiliates of the Sponsor using a EBITDA/cash interest calculation) for each fiscal quarter. (2) Maximum Consolidated Leverage Ratios (to be defined in a manner consistent with transactions with affiliates of the Sponsor using a net (of all unrestricted cash and cash equivalents) debt/EBIDTA calculation) solely as of the last day of each four quarter period. (3) For purposes of determining compliance with the financial covenants, any equity contribution (which such equity shall be common equity or other equity on terms and conditions reasonably acceptable to - --------------- * Specific covenant levels to be agreed, which shall reflect at a least a 30% cushion from the Closing Date Sponsor Model. I-A-10 the Lenders) made to Holdings after the Closing Date and on or prior to the day that is 10 days after the day on which financial statements are required to be delivered for a fiscal quarter will, at the request of Borrower, be included in the calculation of Consolidated EBITDA for the purposes of determining compliance with financial covenants at the end of such fiscal quarter and applicable subsequent periods (any such equity contribution so included in the calculation of Consolidated EBITDA, a "Specified Equity Contribution"), provided that (a) in each four fiscal quarter period, there shall be a period of at least two fiscal quarter in which no Specified Equity Contributions made, and (b) the amount of any Specified Equity Contribution shall be no greater than the amount required to cause Borrower to be in compliance with the financial covenants. Events of Default: The following, in each case, usual for facilities and transactions of this type for affiliates of the Sponsor (including with respect to materiality thresholds and grace periods) nonpayment of principal when due; nonpayment of interest, fees or other amounts after a grace period to be agreed upon; material inaccuracy of representations and warranties; violation of other covenants (subject, in the case of certain such covenants, to a grace period to be agreed upon); cross-default and cross-acceleration to other material debt; bankruptcy events; certain ERISA events; material judgments; actual or asserted material invalidity of any Guarantee, security interest or subordination provisions; and change of control (the definition of which is to be agreed). Indemnification: Customary for transactions of this type. Lenders' Counsel: Shearman & Sterling LLP. I-A-11 ANNEX I-B "Applicable Margin" shall mean initially 2.00%, subject to pricing grid to be determined for each of the Term Loan Facility and the Revolving Credit Facility. ANNEX II-A SUMMARY OF CERTAIN TERMS OF SENIOR SUBORDINATED BRIDGE FACILITY Unless otherwise defined herein, capitalized terms used herein and defined in the letter agreement to which this Annex II-A is attached (the "Commitment Letter") are used herein as therein defined. Borrower: Same as in the Senior Term Sheet. Bridge Facility: Bridge loan facility in an aggregate principal amount of $215.0 million (the "Bridge Facility"). In addition, if less than 100% of the Existing Subordinated Notes are retired, any principal amount outstanding will reduce the Bridge Facility on a dollar-for-dollar basis. Use of Proceeds: The loans made pursuant to the Bridge Facility (the "Bridge Loans") solely (i) to finance the Merger, (ii) to consummate the Refinancing and (iii) to pay the fees and expenses incurred in connection with the Transaction. Maturity: The final maturity date of the Bridge Facility shall be 12 months from the Closing Date (the "Bridge Loan Maturity Date" or "Rollover Date"). Availability: No amount of Bridge Loans once repaid may be reborrowed. Bridge Administrative Agent: Banc of America Bridge LLC (in such capacity, the "Bridge Administrative Agent"). Bridge Syndication Agent: Credit Suisse. Bridge Lead Arrangers and Book Runners: Banc of America Securities LLC and Credit Suisse Securities (USA) LLC (in such capacities, the "Bridge Joint Lead Arrangers"). Bridge Lenders: Banc of America Bridge LLC, Credit Suisse and/or a syndicate of other lenders formed by the Bridge Lead Arranger reasonably acceptable to the Borrower (the "Bridge Lenders"). Guaranties: Same Guarantors as in the Senior Term Sheet. Ranking: The Bridge Loans will be unsecured, senior subordinated obligations of the Borrower, subordinated to the Senior Credit Facilities pursuant to subordination provisions customary for high-yield securities and ranking pari passu with all other senior subordinated obligations of the Borrower and senior to all subordinated obligations of the Borrower. The Guarantees will be unsecured, senior subordinated obligations of each Guarantor, subordinated to such Guarantor's guarantee under the Senior Credit Facilities pursuant to subordination provisions customary for high-yield securities and ranking pari passu with all other senior subordinated obligations of such Guarantor and senior to all subordinated obligations of such Guarantor. Voluntary Prepayments/ Commitment Reductions: Voluntary prepayments of the Bridge Loans may be made at any time, without premiumor penalty together with accrued interest and breakage costs. Mandatory Repayments: Mandatory repayments of Bridge Loans shall be required, in each case only to the extent such amounts are not required to be paid to the Senior Lenders under the Senior Credit Facilities, from (a) 100% of the proceeds (net of taxes and costs and expenses in connection with the sale) from asset sales to third parties outside the ordinary course of business (to be defined in a manner customary for affiliates of the Sponsor) and (ii) reinvestment rights that are substantially identical to those contained in the Senior Credit Facilities), (b) 100% of the net proceeds from issuances of debt securities by Holdings and its subsidiaries other than proceeds from the issuance of Permanent Securities to refinance outstanding Bridge Loans, and (c) 100% of the proceeds from public issuances of any equity of Holdings or any of its restricted subsidiaries, in each case with exceptions and baskets customary for affiliates of the Sponsor to be agreed upon. Change of Control: In the event of a Change of Control (to be defined in a manner customary for similar facilities for affiliates of the Sponsor, each Bridge Lender will have the right to require the Borrower, and the Borrower must offer, to prepay the outstanding principal amount of the Bridge Loans, without premium or penalty, plus accrued and unpaid interest thereon to the date of prepayment. Prior to making any such offer, the Borrower will, within 60 days of the Change of Control, repay all obligations under the Senior Credit Facilities or use commercially reasonably efforts to obtain any required consent of the Senior Lenders under the Senior Credit Facilities to make such prepayment of the Bridge Loans. Permitted Refinancing: If the Bridge Loans have not been previously prepaid in full for cash (with Permanent Securities or otherwise) on or prior to the Rollover Date, the principal amount of the Bridge Loans outstanding on the Rollover Date shall automatically be refinanced by unsecured, senior subordinated rollover loans with a maturity of nine years after the Bridge Loan Maturity Date (the "Rollover Loans") and otherwise having the terms set forth in Annex II-B. On or after the Rollover Date, each Bridge Lender will have the right to exchange the II-A-2 outstanding Rollover Loans held by it for unsecured, senior subordinated exchange notes of the Borrower having the terms set forth in Annex II-C, provided that the initial issuance of Exchange Notes shall be no less than $50 million. Interest Rates: Interest shall be payable quarterly in arrears at a rate per annum equal to three-month LIBOR plus the Applicable Margin per annum. The Applicable Margin for Bridge Loans shall initially be 5.50%, and the Applicable Margin shall increase by an additional 0.50% at the six-month anniversary of the Closing Date and by an additional 0.50% at the end of each subsequent three-month period for as long as the Bridge Loans are outstanding; provided that the interest rate shall not exceed the amount specified in the Fee Letter (the "cap"). Default Interest: Overdue principal, interest and other amounts shall bear interest at a rate per annum equal to the rate which is 2% in excess of the rate then borne by the Bridge Loans. Such interest shall be payable on demand. Right to Assign Bridge Loans: After the Closing Date, the Bridge Lenders shall have the right to assign their interest in the Bridge Loans in whole or in part in a minimum assignment amount of $5.0 million and increments of $1.0 million in excess thereof in compliance with applicable law to any third parties; provided, however, that prior to the Bridge Loan Maturity Date, so long as no payment or bankruptcy Event of Default has occurred and is continuing, the consent of the Borrower shall be required (such consent not to be unreasonably withheld or delayed) with respect to any assignment, if, subsequent thereto, Bridge Lenders on the Closing Date would hold, in the aggregate, less than 50.1% of the outstanding Bridge Loans. Governing Law: All documentation shall be governed by New York law. Conditions Precedent: Under the Bridge Credit Documentation, the availability of the Bridge Loans shall be conditioned upon satisfaction of the conditions precedent set forth in Annex III to the Commitment Letter. The Bridge Credit Documentation shall not contain (a) any material conditions precedent other than the conditions precedent set forth in Annex III to the Commitment Letter or (b) any material representation or warranty, affirmative or negative covenant or event of default not set forth in the Commitment Letter or the Annexes thereto, the accuracy, compliance or absence, respectively, of or with which would be a condition to the availability of the Bridge Loans. Representations and Warranties: Those representations and warranties usual and customary for transactions of this type with affiliates of the Sponsor and consistent, to the extent applicable, with those in the Senior Secured Facilities. II-A-3 Covenants: Covenants usual and customary for transactions of this type with affiliates of the Sponsor so long as and to the extent reasonably acceptable to the Bridge Joint Lead Arranger (but, in any event, no financial maintenance covenants), with affirmative covenants consistent, to the extent applicable with those in the Senior Secured Facilities and including a covenant for the Borrower to use its commercially reasonable best efforts to refinance the Bridge Facility with the proceeds of the Permanent Securities as promptly as practicable following the Closing Date. For the avoidance of doubt, the negative covenants shall be based on those contained in any preliminary offering memorandum used prior to the Closing Date, with certain provisions, prior to the Bridge Loan Maturity Date, to be more restrictive as agreed. Events of Default: Those events of default usual and customary for transactions of this type with affiliates of the Sponsor (it being understood that the Bridge Facility shall not contain a cross-default to other indebtedness but shall include a cross-acceleration to other indebtedness). For the avoidance of doubt, the events of default shall be based on those contained in any preliminary offering memorandum used prior to the Closing Date with certain provisions, prior to the Bridge Loan Maturity Date, to be more restrictive as agreed. Expenses: Customary provisions regarding expense reimbursement, which reimbursement shall be subject to the occurrence of the Closing Date. Fees: As provided in the Fee Letter. Bridge Lenders' Counsel: Shearman & Sterling LLP. II-A-4 ANNEX II-B SUMMARY OF CERTAIN TERMS OF SENIOR SUBORDINATED ROLLOVER FACILITY Capitalized terms not otherwise defined herein have the same meanings as specified therefor in the Commitment Letter to which this Annex II-B is attached. Borrower: Same Borrower as in Senior Term Sheet and Bridge Term Sheet. Guarantors: Same Guarantors as in Senior Term Sheet and Bridge Term Sheet. Rollover Facility: Unsecured, senior subordinated rollover loans (the "Rollover Loans") in an initial principal amount equal to 100% of the outstanding principal amount of the Bridge Loans on the Rollover Date. The Rollover Loans will be available to the Borrower to refinance the Bridge Loans on the Rollover Date. The Rollover Loans will be governed by the definitive documents for the Bridge Loans and, except as set forth below, shall have the same terms as the Bridge Loans. Ranking: Same as Bridge Loans. Interest Rate: Interest shall be payable quarterly in arrears at a rate per annum equal to three-month LIBOR in effect from time to time plus the Applicable Margin per annum. The Applicable Margin for the Rollover Loans shall be the Applicable Margin on Bridge Loans in effect on the Rollover Date (and as increased on such date). At the six-month anniversary of the Rollover Date, the interest rate shall increase by 0.50% and by an additional 0.50% at the end of each subsequent three-month period; provided that the interest rate shall not exceed the amount specified in the Fee Letter (the "cap"). Overdue amounts shall bear interest at a rate per annum equal to the rate which is 2% in excess of the rate then borne by the Rollover Loans. Such interest shall be payable on demand. Maturity: Nine years after the Bridge Loan Maturity Date (the "Rollover Maturity Date"). Optional Prepayment: For so long as the Rollover Loans have not been exchanged for unsecured, senior subordinated exchange notes of the Borrower as provided in Annex II-C, they may be prepaid at the option of the Borrower, in whole or in part, at any time, together with accrued and unpaid interest to the prepayment date (but without premium or penalty). Mandatory Prepayments: The mandatory prepayments applicable to the Rollover Loans will conform to those contained in the Indenture (as defined in Annex II-C to the Commitment Letter). Right to Assign Rollover Loans: The Bridge Lenders shall have the right to assign their interest in any Rollover Loans in whole or in part in compliance with applicable law to any third parties only with the prior written consent of the Bridge Administrative Agent (not to be unreasonably withheld or delayed). Rollover Covenants: From and after the Rollover Date, the covenants applicable to the Rollover Loans will conform to those contained in the Indenture. Events of Default: From and after the Rollover Date, the events of default applicable to the Rollover Loans will conform to those contained in the Indenture. Governing Law: New York. Expenses: Same as the Bridge Loans. Fees: As provided in the Fee Letter. II-B-2 ANNEX II-C SUMMARY OF CERTAIN TERMS OF SENIOR SUBORDINATED EXCHANGE NOTES Capitalized terms not otherwise defined herein have the same meanings as specified therefor in the Commitment Letter to which this Annex II-C is attached. Borrower: Same Borrower as in Senior Term Sheet and Bridge Term Sheet. Guarantors: Same Guarantors as in Senior Term Sheet and Bridge Term Sheet. Ranking: Same as Bridge Loans. Exchange Notes: At any time on or after the Rollover Date, Rollover Loans due to any Bridge Lender may, at the option of such Bridge Lender, be exchanged for an equal principal amount of unsecured, senior subordinated exchange notes of the Borrower (the "Exchange Notes"), provided that the initial issuance of Exchange Notes shall be no less than $50 million. The Borrower will issue the Exchange Notes under an indenture that complies with the Trust Indenture Act of 1939, as amended (the "Indenture"). The Borrower will appoint a trustee reasonably acceptable to the holders of the Exchange Notes. The Indenture will include provisions customary for an indenture governing high-yield debt securities of affiliates of the Sponsor. Except as expressly contemplated above and in Annex II-B, the Exchange Notes shall have the same terms as the Rollover Loans. Interest Rate Redemption Provision: Each Exchange Note will initially bear interest at the rate in effect on the Rollover Loans for which it is exchanged and, thereafter, the interest rate on the Exchange Notes shall be determined in the same manner as set forth in Annex II-B with respect to the Rollover Loans. For so long as they bear interest at an increasing rate of interest, the Exchange Notes will be redeemable at the option of the Borrower, in whole or in part at any time, at par plus accrued and unpaid interest to the redemption date. Each holder of Exchange Notes shall, upon a sale to a third party, have the option to fix the interest rate on the Exchange Notes to a rate that is equal to the then applicable rate of interest borne by the Exchange Notes. In such event, such Exchange Notes will be non-callable until the fifth anniversary of the Closing Date (except pursuant to an equity claw-back customary for the Sponsor and a redemption right at a customary make-whole price to be agreed) and will be callable thereafter at par plus accrued interest plus a premium equal to one-half of the coupon in effect on the date on which the interest rate was fixed, declining ratably to par on the date that is two years prior to maturity of the Exchange Notes. The Exchange Notes will provide for mandatory repurchase offers customary for high yield debt securities of affiliates of the Sponsor. Registration Rights: Within 90 days after the issuance of the Exchange Notes the Borrower shall file a shelf registration statement with the Securities and Exchange Commission and the Borrower shall use its commercially reasonable best efforts to cause such shelf registration statement to be declared effective within 180 days of the filing of the registration statement and keep such shelf registration statement effective, with respect to resales of the Exchange Notes, for as long as it is required by the holders to resell the Exchange Notes (but in no event longer than two years from the first issuance of the Exchange Notes). Upon failure to comply with certain requirements of the registration rights agreement (a "Registration Default"), the Borrower shall pay additional interest to each holder of Exchange Notes with respect to the first 90-day period immediately following the occurrence of the first Registration Default in an amount equal to one-quarter of one percent (0.25%) per annum on the principal amount of Exchange Notes held by such holder. The amount of the additional interest will increase by an additional one-quarter of one percent (0.25%) per annum on the principal amount of Exchange Notes with respect to each subsequent 90-day period until all Registration Defaults have been cured, up to a maximum amount of additional interest for all Registration Defaults of 0.50% per annum. Governing Law: New York. II-C-2 ANNEX III CONDITIONS PRECEDENT TO CLOSING $375.0 MILLION SENIOR CREDIT FACILITIES $215.0 MILLION SENIOR SUBORDINATED BRIDGE FACILITY Capitalized terms not otherwise defined herein have the same meanings as specified therefor in the Commitment Letter to which this Annex III is attached. The closing and the initial extension of credit under the Senior Credit Facilities and the extension of the Bridge Loans under the Bridge Facility will be subject to satisfaction of the following conditions: (i) Facilities Documentation (as defined in the Commitment Letter) consistent with the Term Sheets and the Commitment Letter (including, without limitation, the Guarantees, which shall be in full force and effect) shall have been executed and delivered to the Joint Lead Arrangers and the Lenders. (ii) The Merger shall have been consummated, or substantially simultaneously with the initial borrowing under the Facilities shall be consummated, in accordance with applicable law and the Merger Agreement (and no provision of the Merger Agreement shall have been waived, amended, supplemented or otherwise modified in a manner material and adverse to the Lenders without the consent of the Joint Lead Arrangers). The Joint Lead Arrangers shall have received certified copies of the Merger Agreement and all certificates and other documents delivered thereunder. The Joint Lead Arrangers shall be reasonably satisfied in all material respects with the terms of any material agreements to be entered into in connection with the Merger Agreement (to the extent furnished to the Joint Lead Arrangers prior to the date hereof, the Joint Lead Arrangers acknowledge such satisfaction). (iii) (A) The Equity Financing shall have been consummated and the Borrower shall have used all cash proceeds received from the Equity Financing to make payments owing in connection with the Transaction before the Borrower utilizes any proceeds of the Facilities for such purpose, (B) in the case of the Senior Credit Facilities, the Senior Lead Arrangers shall have received satisfactory evidence of receipt by the Borrower of not less than $215.0 million (as reduced in accordance with the terms under the heading "Mandatory Repayments" set forth in Annex II-A) cash proceeds from the advance of the Bridge Loans or the issuance by the Borrower of the Senior Subordinated Notes, (C) in the case of the Bridge Facility, the Bridge Lead Arrangers shall have received evidence satisfactory to the Bridge Lead Arrangers of receipt by the Borrower of up to $325.0 million cash proceeds from the advance of the Term Loans. The conditions set forth in clauses (B) and (C) shall be satisfied notwithstanding the receipt by the Borrower of less cash proceeds than as set forth therein so long as the amount funded pursuant to the Facilities and/or the Senior Subordinated Notes, together with the Equity Contribution, shall equal the amount required to consummate the Transaction. (iv) After giving effect to the Transaction, Holdings and its subsidiaries shall have no outstanding indebtedness or preferred stock, except for indebtedness incurred pursuant to (w) the Senior Credit Facilities, (x) the Senior Subordinated Notes (or if the Bridge Facility is funded, the Bridge Loans, the Rollover Loans or the Exchange Notes), (y) any Existing Subordinated Notes that have not been purchased by the Company pursuant to the Tender Offer and Consent Solicitation and (z) existing indebtedness and preferred stock with amounts and the terms and conditions of such indebtedness or preferred stock to be reasonably satisfactory to the Joint Lead Arrangers (collectively, "Existing Indebtedness"). Without limiting the foregoing, (x) the Existing Credit Agreement shall have been terminated, all outstandings thereunder shall have been repaid in full, and all liens pursuant thereto shall have been terminated, and (y) the Minimum Consent Condition shall have been satisfied, and the Existing Subordinated Notes Indenture shall have been amended as contemplated by clause (y) of the third sentence of the first paragraph of the Commitment Letter. (v) The Lenders shall have received (A) legal opinions from counsel, and covering matters, reasonably acceptable to the Joint Lead Arrangers (and customary for transactions with affiliates of the Sponsor) and (B) from the chief financial officer of the Company a solvency certificate, in customary form and substance. All costs, fees, expenses (including, without limitation, legal fees and expenses) and other compensation contemplated hereby, by the Fee Letter and the Engagement Letter, payable to the Lenders, the Joint Lead Arrangers and the Senior Administrative Agent shall have been paid to the extent due. (vi) The Joint Lead Arrangers and the Lenders shall have received (I) unaudited consolidated financial statements of the Company and its subsidiaries for any interim quarterly periods that have ended since the audited financial statements referred to in preceding clause (I) for which financial statements are available (it being understood that such unaudited consolidated financial statements shall be "available" no later than the 45th day following the last day of the Company's fiscal quarter, as the case may be), with such unaudited financial statements of the Company and its subsidiaries to be prepared in accordance with generally accepted accounting principles in the United States for interim reporting and (II) pro forma financial statements as to the Borrower and its subsidiaries giving effect to the Transaction for the most recently completed fiscal year and any subsequent interim quarterly period, which shall meet the III-2 requirements of Regulation S-X under the Securities Act of 1933, as amended (the "Securities Act"), and shall be subject to such other adjustments as are agreed by the Joint Lead Arrangers and the Borrower. (vii) Delivery of other closing documentation customary for facilities of this type, including certificates of incorporation and by-laws (or equivalent organizational documents), resolutions, good standing certificates, and insurance certificates. (viii) The Borrower shall have delivered such documentation and other information as is reasonably requested in writing by the Joint Lead Arrangers in order to allow the Joint Lead Arrangers to comply with applicable "know your customer" and anti-money laundering rules and regulations, including without limitation the PATRIOT act. III-3 -----END PRIVACY-ENHANCED MESSAGE-----